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Chapter I: Introduction and Aim 
1.1 Degradable Polymers 
Biodegradable polymers have a huge field of applications, from agricultural over daily life 
usage to the biomedical area.1–3 The global production of biodegradable polymers increases 
annually. In 2008 174,000 metric tons were produced. In 2011 this value tripled. In 2015 the 
production will probably increase to 714,000 metric tons (Figure 1). 
 
Figure 1:  Global production capacity for bioplastics according to the European bioplastics 
source.4 
The growing need for biodegradable polymers is mainly caused by suitable degradation 
kinetics for different applications.5 In terms of application biodegradable polymers can be 
divided into two major groups: the medical and the ecological applications.6 For example the 
poly(lactic-co-glycolic acid) (PLGA) and collagen are used for scaffolding applications. In 
this case the biodegradability kinetics of the scaffold polymer should correlate with the 
growth velocity of the tissue regeneration. Biodegradable polymers like 
polyhydroxyalkanoates (PHAs) can also be used as potential carrier to deliver drugs to 
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infected body parts in an effective and non-invasive way.7 The copolymer hy-PEI-g-PCl-b-
PEG is used for DNA transfection.8 For these kinds of usage the biodegradable polymer 
should be stable for a certain time in a physiological environment until it can serve its purpose. 
Eventually the polymer is supposed to degrade completely to leave no foreign materials in the 
body. Biodegradable polymers for ecological applications like Ecoflex® (BASF) and Ecoflex® 
starch blends are used as food package, in agriculture and forestry. Ecoflex® film can be 100% 
degraded in compost.9 Some typical biodegradable polymers are classified and shown in 
Figure 2. 
 
Figure 2: Application fields of biodegradable polymers. PHA: polyhydroxyalkanoates: hy-
PEI-g-PCl-b-PEG: hyper-branched-polyethylenimine-grafted-polycaprolacton-co-
polyethylenglycol; PLGA: poly(L-lactic-co-glycolic acid); PLLA: poly(L-lactide); PCl: 
polycaprolacton; PBS: poly(butylene succinate); PES: poly(ethylene succinate). 
In order to synthesize suitable degradable polymers for different applications it is important to 
understand the relationship between polymer architecture and degradation mechanism. Most 
saturated carbon backbone in a polymer is not degradable, but polymers like polyesters, 
polyamides are degradable. This illustrates the importance of heteroatoms in the main chain in 
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order to open degradation pathways. Hence to synthesize degradable polymers it is necessary 
to introduce functional groups into the polymer chain.10 
Cyclic ketene acetals are intensively investigated in the synthesis of degradable polymers. In 
the 1970’s Bailey’s group synthesized for the first time the cyclic ketene acetal 2-methylene-
1,3-dioxepane (MDO) with an exo-methylene group, which readily undergoes radical ring-
opening polymerisation.11 Under ideal reaction conditions polyesters are formed by this 
radical ring-opening polymerization. Furthermore other cyclic ketene acetals, like 5,6-benzo-
2-methylene-1,3-dioxepane (BMDO), were also synthesized and investigated for ring-opening 
polymerization (ROP) reactions (Figure 3a). In Agarwal’s group the homopolymerisation and 
copolymerization of cyclic ketene acetals are intensively studied to introduce ester groups in a 
polyvinyl polymer backbone by radical polymerization (Figure 3b).12 This radical 
copolymerisation with cyclic ketene acetats gives the opportunity to incorporate ester groups 
in ordinary plastics, which until today are considered inert against biological degradation. 
(Figure 3c).  
 
Figure 3: a) MDO and BMDO structures; b) radical ring-opening polymerization of cyclic 
ketene acetals; c) copolymerization of vinyl monomers and cyclic ketene acetals. 
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1.2 Deoxyribonucleic Acid (DNA) Transfection 
 Gene Therapy 1.2.1
Genes are the basic physical and functional units of heredity, which are carried on 
chromosomes.13 Cancer and many genetic diseases are caused by genetic disorders which 
means that the encoded proteins are unable to carry out their normal functions. Gene therapy 
is a promising method to treat these genetic defects by transferring functional genetic material 
as a pharmaceutical agent into specific cells of the patient.14,15 For this treatment the 
functional genes have to be delivered into the eukaryotic cells to replace the mutated gene. 
After the correction of the abnormal gene, gene expression can be observed. 
 Gene Carriers 1.2.2
The major challenge for gene therapy is the delivery of sufficient DNA into specific target 
cells to achieve the desired gene expression.16 DNA can be delivered into the cell nucleus via 
specific carriers, two major groups of these carriers are the viral gene carriers and the non-
viral gene carriers (Figure 4).17 
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Figure 4: Classification of the gene carriers for gene therapy. 
a) Viral Gene Carriers 
Since viruses are the simplest life form and only consist of ribonucleic acid (RNA) and a 
protein shell; they can be used to transport functional DNA into eukaryotic cells. A virus 
generally attaches itself onto the surface of a target cell and introduces its RNA into the host 
cell by an injection mechanism. The disadvantages of viral gene carriers are the high cost, 
high immunogenicity and safety concerns.18 
b) Non-Viral Gene Carriers 
In contrast to the viral gene carriers, the non-viral gene carriers have the advantages of low-
toxicity, non-immunogenicity and feasibility to be produced on a large scale. Non-viral gene 
carriers can be divided into three main groups, physical means, cationic lipids and synthetic 
polycations for gene transfection (Figure 4).19–22  
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Synthetic Polycations. Non-viral gene delivery systems based on synthetic polycations 
have recently attracted significant attention because of easy up-scaling, storage stability, high 
safety and low cost.23,24 
A good polymeric gene carrier works as follows (Figure 5). First the cationic polymer forms a 
complex with the negatively charged DNA, which is named polyplex. The polyplexes are 
based on electrostatic interactions between the phosphate groups of the DNA and the 
positively charged polycation. A suitable polycation DNA carrier protects the DNA from 
degradation in the physiological environment and provides an easy cellular uptake into the 
eukaryotic cells. Cells prefer small polyplexes with a positive zeta potential. Inside the cell 
the polymer releases the DNA near or inside the cell nucleus, so the DNA can be transcribed 
and translated. After the translation of the gene the gene translation is successful. The gene 
expression can be detected. 
 
Figure 5: DNA transfection mechanism using a cationic polymer as carrier.         
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In the last few years, polyethylenimine (PEI) has become a gold standard for non-viral gene 
delivery due to its high transfection efficiency.25 The main drawback of PEI is the high 
cytotoxicity and non-degradability. Recently a lot of attention is being focused on the 
reduction of the polymer carriers’ cytotoxicity, the immunogenicity and increase the 
biodegradability and the transfection efficiency. For example Kwon and coworkers have 
shown a biodegradable hybrid recombinant block copolymer p[Asp(DET)]53ELP(1–90), 
which possesses a thermo-responsive elastin-like polypeptide (ELP) segment and a 
diethylenetriamine (DETA) modified poly-L-aspartic acid segment, for gene delivery 
(Figure 6).26  
                                 
Figure 6: Chemical structure of linear PEI, p[Asp(DET)]53ELP(1–90) and PDMAEMA (left 
to right).26      
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Kissel and coworkers have demonstrated a series of amphiphilic copolymers of hy-PEI-g-
PCL-b-PEG, which are biodegradable. They showed that the transfection efficiency of this 
copolymer depends on the grafting density of the PCL-b-PEG chains (Figure 7).27  
 
Figure 7: Polyplexes of amphiphilic copolymer hy-PEI-g-PCL-b-PEG grafted with different 
density of the PCL-b-PEG chains.27 
 
Poly(N,N-dimethylaminoethyl methacrylate) (PDMAEMA)  and its copolymers are recently 
also intensively investigated as alternative non-viral carrier to PEI and PEI based copolymers. 
Zhong and his colleagues presented a triblock copolymer poly-(dimethylaminoethyl 
methacrylate)-SS-poly(ethylene glycol)-SS-poly-(dimethylaminoethyl methacrylate) 
(PDMAEMA-SS-PEG-SS-PDMAEMA) which is able to form reversibly shielded DNA 
polyplexes for gene transfection.28 Figure 8 shows schematically the PDMAEMA-SS-PEG-
SS-PDMAEMA triblock copolymer’s ability to effectively condense DNA into partially 
shielded nano-sized polyplexes and the uptake by a cell. In the cells the disulfide bonds cleave 
and result in rapid deshielding and DNA release into the cytoplasm and cell nucleus. 
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Figure 8: (PDMAEMA-SS-PEG-SS-PDMAEMA) triblock copolymer for the gene 
transfection procedure.28 
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 Detection Method for Gene Transfection Efficiency – 1.2.3
Luciferase Assay 
The DNA transfection efficiency can be determined by the luciferase assay.29 This assay uses 
the bioluminescence of the oxidizing enzyme firefly luciferase from the firefly Photinus 
pyralis to yield an easily detectable signal (Figure 9). First a firefly luciferase sequence 
containing fragment of a plasmid is used. After successful transfection, the DNA-fragment is 
transcribed and translated into the enzyme luciferase. After cell lysation luciferin is added as 
the substrate, which at first undergoes an ATP-mediated (adenosine triphosphate) activation. 
This activated AMP-derivative (adenosine monophosphate) is subsequently oxidized to 
oxyluciferin. After that oxyluciferin, which in this reaction is formed in an excited electronic 
state, emits a photon while returning to its ground state. Photon emission can be easily 
detected and quantified. The measured light intensity is directly proportional to the protein 
expression level. 
 
Figure 9: Illustration of the luciferase assay. 
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 Detection Method of Polyplex Stability – Sybr Gold Assay 1.2.4
and Heparin Assay 
a) Sybr Gold Assay 
The Sybr Gold assay is the most sensitive assay to quantitatively measure the condensation 
ability of a polymer/DNA complex. Sybr Gold is a dye which has the ability to bind to free 
DNA forming a Sybr Gold/DNA complex, which absorbs blue light and emits green light.30 
In contrast, the Sybr Gold cannot bind to already complexed DNA as in a polyplex 
(Figure 10). The sensitivity of this dye is 25 to 100 fold increased in comparison to 
ethidiumbromide.31 It has furthermore a very weak background signal (ratio 1:1000), so the 
detected fluorescence signal can be directly correlated to the amount of free DNA. 
  
Figure 10: Illustration of the Sybr Gold assay. 
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b) Heparin Competition Assay 
Heparin is a glycosaminoglycan with a sulfonic acid group, which is medically used as a 
blood anticoagulant. It has a high negative charge density as shown in Figure 11.32,33 Since 
certain in vivo polymers as well the cell surfaces in general are negatively charged, it can 
simulate the in vivo environment in a simple assay. 
In this assay Heparin is used to compete with the DNA for the affinity to the polymer. 
Figure 11 shows the competing reactions between Heparin and the DNA. The binding of 
Heparin to the polymer sets the DNA free. The amount of released DNA, which can be 
quantified by the change in the fluorescence intensity determined with the Sybr Gold assay, 
correlates with the stability of the DNA/polymer complex.  
 
Figure 11: Illustration of the Heparin competition assay. 
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 Cytotoxicity Test Using 3-(4,5-Dimethylthiazol-2-yl)-2,5-1.2.5
Diphenyltetrazolium Bromide (MTT)  Methods 
The MTT assay method is an established cell viability test method which is used for the 
cytotoxicity test.34 This test is a colorimetric assay which measures the activity of enzymes 
that reduce MTT to formazan dyes which have a purple color. This reaction is shown in 
Figure 12, the tetrazole yellow ring is reduced to form the formazan purple in living cells.  
 
 
Figure 12: Illustration of the MTT test and the MTT reaction. 
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The test procedure was performed as follows. First the cells needed one to two weeks to grow. 
Then the cells were counted and seeded into a 96-well plate. About 8000 cell were placed in 
each well. After 24 h incubation of the cells in the well plate, the medium was exchanged and 
polymer solutions with different concentrations were added into the wells. After a further 
incubation for 24 hours, MTT was added into each well. Then the reaction shown in Figure 12 
can occur. The living cells produce an enzyme, which can reduce the MTT (yellow) to the 
formazan (purple). Finally, the absorbance of this colored solution can be quantified by 
measuring at a certain wavelength (between 500 and 600 nm) with a spectrophotometer. 
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1.3 Sustained Drug Delivery  
 General Introduction of Sustained Drug Delivery 1.3.1
Drug delivery methods were developed very fast in the last few years. Conventional drug 
delivery methods conventioned are drops, pills, ointments and intravenous solutions. Recently 
a number of polymers have been developed as new drug delivery systems. Drug delivery 
carriers are used to minimize drug degradation and loss as well as to increase drug 
biocompatibility.35 An optimization of drug loading and release properties, a long shelf life 
and low cytotoxicity are the important factors for drug delivery systems. Recently it has been 
shown that colloidal drug carriers like micelles, vesicles and nanoparticles are very promising 
drug delivery systems.36 Figure 13 shows the most common colloidal drug carrier methods. 
 
Figure 13: Illustration of the common pharmaceutical carriers.37  
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a) Micelles as Drug Carriers 
In this case amphiphilic block copolymers are used to form micelles by self-assembly with a 
size between 5 and 50 nm in an aqueous solution.38 The drugs can be physically entrapped in 
the core of the micelles. The hydrophilic blocks of the micelles can form hydrogen bonds with 
the aqueous phase, so that a tight shell around the micelle core is formed. This shell can 
prevent recognition by the reticuloendothelial system. Therefore preliminary elimination of 
the micelles from the bloodstream cannot occur.37 The hydrophobic part of the micelle (inside) 
can protect the drug against hydrolysis and degradation. 
The advantage of this system is the easy modification of the chemical composition. The size 
of the micelles can be readily controlled by the amphiphilic block length. 
b)  Dendrimers as Drug Carriers 
Dendrimers are nanometer sized (1-100 nm) three dimensional highly branched polymers, 
which have attracted a lot of attention as controlled and targeted drug delivery systems. 
Dendrimers are known as well defined, mono disperse polymers which can bear various 
modificable surface groups.39 The structure of dendrimers consists of an initiator core, 
branched repeating units and functional end groups on the outmost layer. Due to the structural 
configuration, a high drug loading by different techniques can be performed. The drug can for 
example be loaded directly by using the covalent conjugation to the surface functional groups 
or using a ionic interaction of the adsorption onto the surface or by exploiting the hydrophobic 
character inside of the branching clefts.40 All these unique properties make the dendrimers a 
potent platform for both hydrophobic and hydrophilic drugs.40 
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c) Liposomes as Drug Carriers 
Liposomes are spherical vesicles which are composed of one or more phospholipid bilayers 
with a drug containing aqueous core. They are able to encapsulate both hydrophilic and 
hydrophobic drugs. Due to the double layer, liposomes can protect the drug from the external 
environments.41  
d) Polymeric Nanoparticles as Drug Carriers 
Polymer nanoparticle carriers (including nanospheres and nanocapsules) are based on random 
or block copolymers which form nanoparticles with a size between 3 and 200 nm. The 
nanosphere carriers are a physically uniformly dispersed matrix system for the drug.42 The 
naonocapsule encapsulates the drug in the core of the hollow spheres. The naonocapsules and 
the nanoparticles are able to protect the drug against enzymatic degradation. Some carriers are 
also able to control the drug release rate.43,44 The drug release can occur by reservoir diffusion 
and material diffusion. It can also be facilitated by chemical control, in which the nano carrier 
polymer degrades for drug cleavage from a polymer chain Figure 14.45  
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Figure 14: Polymer release mechanisms. A) common release mechanism diffusion through a 
polymer shell; B) drug uniformly distributed through the polymeric matrix; C) drug released 
by chemical mechnisms such as degradation of the polymer.45 
In this work a degradable nanoparticle polymer carrier was synthesized and characterized. 
1.4 Aim of This Thesis 
The aim of this thesis is to synthesize degradable polymers for gene transfection, for sustained 
drug delivery and for antibacterial applications. To achieve these aims, cyclic ketene acetals 
like BMDO and MDO have been copolymerized with appropriate functional vinyl monomers 
like HEMA and DMAEMA using radical polymerization chemistry. 
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Chapter  II: Degradable Polymers for DNA Transfection 
2.1 Introduction 
Gene therapy is a very promising approach for the potential treatment of genetic and inherited 
diseases.14,15 Substantial research has already been carried out in the last few decades on the 
development of gene delivery vectors.46–48 In spite of the high transfection efficiency of viral 
gene vectors, there is an ever increasing amount of number of literature on the use of non-
viral gene delivery vehicles for gene therapy. This is to overcome the basic drawbacks of viral 
vectors which are immune response, limitations in the size of inserted DNA, difficulty in 
large scale pharmaceutical grade production etc.17 Some non-viral DNA delivery systems 
include pure plasmid DNA, lipoplexes (DNA complexed with cationic lipids), polyplexes 
(nucleic acid complexes with polycations and encapsulated DNA in degradable polymer 
matrices). For example, cationic polymers show the ability to form polyplex with DNA by 
electrostatic interactions due to its polyanionic character.19,49–52 An example of a frequently 
studied polycation for this purpose is polyethyleneimine (PEI), a gold standard with buffering 
properties (at physiological pH only 25% of the amine groups are protonated) but with the 
major drawback of cytotoxicity (half maximal inhibitory concentration (IC50) = ~ 8 µg/ml).53 
Recently, attention has been given to poly(N,N-dimethylaminoethyl methacrylate) 
(PDMAEMA) as a non-viral gene delivery system with buffering capacity and less 
cytotoxicity (IC50 = ~ 40µg/ml) (pKa = 7.5). This polymer is prepared by radical 
polymerization of the corresponding vinyl monomer. It was shown for the first time in 1996 
by Hennink et al. that PDMAEMA is an interesting vector for designing of a gene transfection 
system.54 
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PDMAEMA contains tertiary amines for the complexation of DNA and reaches 90% of the 
transfection efficiency of PEI (branched PEI 25 kDa). Since then, several aspects of this 
transfection reagent have been modified i.e. the role of molecular weight, polyplex size and 
transfection parameters, pH, ionic strength, temperature, viscosity, polymer/plasmid-DNA (p-
DNA) ratio and the presence of stabilizers on transfection efficiency of PDMAEMA.55–59 
Despite so much research, the key problem of polycations like PEI and PDMAEMA is their 
non-biodegradable nature, notable toxicity and the need for further improvement of 
transfection efficiency. 
Vinyl polymers like PDMAEMA, which can be easily synthesized by radical polymerization, 
could be further designed to meet these requirements. Recently, Oupicky et al. reported 
PDMAEMA copolymers with reducible –S-S- disulfide linkages using reversible addition 
fragmentation transfer (RAFT) polymerization with comparable cytotoxicity and gene 
transfection efficiency like homo PDMAEMA for the first time.60 Unfortunately, no data (in 
vivo or in vitro) regarding biodegradation behavior was provided. 
To solve the non-degradability issue of PDMAEMA, we recently showed the possibility of 
forming a degradable and less toxic PDMAEMA by introducing ester linkages into the 
PDMAEMA backbone. We consider radical-ring-opening polymerization of cyclic ketene 
acetals a promising method for introducing degradable ester linkages into the polymer 
backbone, which can be used to develop new gene transfection systems. Cyclic ketene acetals 
are the isomers of the corresponding cyclic lactones and can undergo radical addition at the 
vinyl double bond with subsequent ring-opening leading to the formation of polyesters. Free-
radical copolymerization of cyclic ketene acetal 5,6-benzo-2-methylene-1,3-dioxepane 
(BMDO), with N, N-dimethylaminoethyl methacrylate (DMAEMA) can lead to the formation 
of degradable PDMAEMA with ester linkages in the backbone.61 The polymers were not 
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soluble in water, therefore quaternization with alkyl bromide was carried out. Regardless of 
copolymer composition, all of the polymers were less cytotoxic than PEI and showed very 
high cell viability. Unfortunately, the system showed poor transfection efficiency which could 
be due to the strong interactions between the positively charged units and DNA. Therefore, 
further improvement was implemented in this system by designing a polymer avoiding 
quaternization of PDMAEMA. Small poly(ethylene glycol) (PEG) hydrophilic blocks were 
introduced onto degradable PDMAEMA units to enhance water solubility and reduce the 
cytotoxicity.62,63 Again, simple free radical chemistry with cyclic ketene acetal 2-methylene-
1,3-dioxepane (MDO) and BMDO als monomer was used for this purpose and a 
poly(ethylene oxide) (PEO) macro-azo-initiator was used. The success of this concept is 
highlighted in this work by giving details about synthesis, cytotoxicity, polyplex formation 
and gene transfection. 
 
 
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2.2 BMDO based Polymers for DNA Transfection 
Zhang, Yi; Zheng, Mengyao; Kissel, Thomas; Agarwal, Seema. Biomacromolecules 2012, 13, 
313-322.64 
 Experimental Part 2.2.1
Materials. PEO macro-azo-initiator (WAKO Company Mn = 24 kDa, PEG block = 
6000 g/mol) and bromoethane (Acros, 99%) were used as received. DMAEMA (Acros) was 
passed through a basic alumina column to remove the inhibitor. Demethylformamide (DMF), 
chloroform, pentane and methanol were distilled before use. BMDO was synthesized 
according to our previous report.65 Luciferase-Plasmid (pCMV-Luc) (LotNo.: PF461-090623) 
was amplified by The Plasmid Factory (Bielefeld, Germany). DMEM low glucose medium 
contains 1g/L glucose and different inorganic salts and vitamins and amino acids to reach a 
neutral pH 7.0-7.5 and osmolarity of 280-350 mOsmol/kg. All other chemicals were obtained 
from Sigma–Aldrich (Steinheim, Germany) and used as received. 
Instrumentation. 1H (400,13 MHz) and 13C (100,21 MHz) spectra were recorded on a Bruker 
DRX-400 spectrometer. Tetramethylsilane was used as internal standard. The molecular 
weight of the polymers were measured with size exclusion chromatography at 25 °C with 1 
liner PSS suprema Max 1000 Å column and a differential refractive index detector (SEC 
curity RI, PSS). 0.3 mol/L formic acid in water was used as an eluent at a flow rate of 
0.5 mL/min. An SEC curity 1100 (PSS) pump was used for the experiment. Linear poly 2-
vinylpyridine was used for calibration. The injected volume was 100 µL and the polymer 
concentration was 1 mg/mL. 
Copolymerization of DMAEMA and BMDO with PEO Azo-initiator (general 
procedure). As an example for polymerization reactions, the procedure for the synthesis of 
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sample 4 is described below. All of the sample names and monomer feed ratios are shown in 
Table 1 and Table 2. 
The monomer BMDO (0.99 g, 6.1 mmol) was dissolved in DMAEMA (0.1 mL, 0.59 mmol) 
in a predried Schlenk tube under an argon atmosphere. The reaction mixture was degassed by 
three freeze-pump-thaw cycles. The PEO azo-initiator with PEG 6000 block (0.41 g, 
6.8×10-2 mmol) was added to the still frozen solution. The Schlenk tube was closed, 
evacuated and refilled with argon three times. This reaction mixture was placed immediately 
in a preheated oil bath at 70 °C for 24 h. Then the Schlenk tube was taken out of the oil bath 
and shock cooled in an ice bath. The reaction mixture was diluted with chloroform and 
precipitated in 200 mL of pentane which yielded a white precipitate. This white polymer was 
washed with a small amount of water then dissolved in chloroform and precipitated in pentane 
again. This procedure was repeated twice and then purified by dialysis (MWCO 20kDa) 
against water. The final copolymer was dried under a vacuum at 40 °C for 48 h. 
Quaternization Reaction of Poly(PEO-co-(BMDO-co-DMAEMA)) Copolymers. 200 mg 
copolymer (samples 1-4) were dissolved in 20 mL chloroform at room temperature in a flask. 
0.5 mL methanol and 2 mL ethylbromide were added to the copolymer solution. The flask 
was placed in a preheated oil bath at 45 °C for 40 h. Afterwards, the solvent was evaporated 
using a rotary evaporator. The residue was dissolved again in methanol and precipitated in 
pentane. This product was then purified by repeatedly dissolving in methanol and 
precipitating in pentane. The final product was dried at 40 °C under vacuum for 48 h. 
Hydrolytic Degradability. In general, 100 mg copolymer was dissolved in a flask containing 
10 mL of 5 wt.% KOH in distilled water. This mixture was kept at room temperature for 48 h. 
Then, 10 mL 10 wt.% HCl was added. This mixture was extracted with chloroform. The 
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aqueous phase was dried with a freeze dryer for 3 days. The remaining solid was than 
characterized with NMR spectroscopy. 
Enzymatic Degradability and Degradation in Buffer. 200 mg copolymer was solved in 
phosphate buffered saline (PBS) buffer (0.1 M, pH = 7.4) and Lipase from Pseudomonas 
Cepacia (10 mg/mL) with a 0.2 mg/mL NaN3 solution. This mixture was then placed at 37 °C 
with shaking for different time. Then the mixture was dried with a freezer dryer for 5 days. 
The remaining solid was also characterized with NMR spectroscopy and GPC. 
Cell Culture. L929 mouse fibroblasts cells (human adenocarcinoma) for MTT assay and 
luciferase assay were seeded at a density of 5.0•103 cells•cm-2 in dishes (10 cm diameter, 
Nunclon Dishes, Nunc, Wiesbaden, Germany). The incubation condition was at 37 °C in a 
humidified 8.5% CO2 atmosphere (CO2-Incubator, Integra Biosciences, Fernwald, 
Germany).66 The medium was exchanged every 3 days. Cells were split after 5 days when 
confluence was reached. 
Cytotoxicity Test using MTT Assay. The cell viability test (MTT assay) was performed 
according to the method of Mosmann.67 Polymer solutions were prepared in a serum 
supplemented tissue culture medium (Dulbecco’s modified Eagle’s medium, supplemented 
with 10% serum, without antibiotic) containing 2•10-3 M glutamine and was sterile filtered 
(0.2 µm, Schleicher&Schüll, Dassel, Germany). 
24 h before the MTT assay, L929 cells (8000 cells/well) were seeded into 96-well plates 
(Nunc, Wiesbaden, Germany). On the day of MTT assay, the culture medium was replaced by 
200 L of a serially diluted polymer medium solution with a different concentration. After a 
further 24 h of incubation at 37 °C, the cell culture medium was replaced with 200 L 
medium containing 20 L sterile filtered MTT (3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl 
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tetrazolium bromide) (Sigma, Deisenhofen, Germany) stock solution in phosphate buffered 
saline (PBS) (5 mg/mL) in each well. The final concentration of MTT in each well was 
0.5 mg/mL. After a 4 h incubation at 37 °C in the dark, the medium was removed and 200 µL 
of DMSO was added in each well to dissolve the purple formazane product. The measurement 
was performed spectrophotometrically with an ELISA reader (Titertek Plus MD 212, ICN, 
Eschwege, Germany) at wavelengths of 570 nm and 690 nm. The calibration of the 
spectrometer to zero absorbance was performed using a culture medium without cells and to 
100% absorbance was performed using control wells containing standard cell culture medium 
but without polymer. The relative viability (%) related to the control wells containing the cell 
culture medium without polymer was calculated by the following equation: 
 
Relative cell growth = ((A 570) test- (A 690) test) / ((A 570) control – (A 690) control)       (1) 
 
Hyperbranched poly(ethylenimine) (hy-PEI 25kDa, BASF, Germany) was used as a positive 
control. The IC50 was calculated using the Boltzman sigmoidal function from Microcal 
Origin1 v 7.0 (OriginLab, Northampton, USA). It shows the polymer concentration, which 
inhibits growth of half of the cells relative to non-treated control cells. The calculation of 
IC50 was fitted logistically by the Levenberg-Marquardt methods of least-squares 
minimization for nonlinear equation under the default conditions using by the following 
equation: 
 
Y = Y0 + (Ym -Y0)/[1+(C/C0)]    (2) 
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where C0 is the IC50 dose, Y is the optical density in a well containing a particular 
polymer/extract of concentration C. Y0 and Ym are the optical density corresponding to 0% 
viability and 100% viability, respectively. 
To observe the cell viability qualitatively, we also used 0.4% trypan blue solution to stain died 
cells, which were incubated with 0.03 mg•mL-1 polymers for 4 h and 24 h. After removing the 
medium in each well, cells were washed with 200 µL PBS buffer and incubated for another 
20 min in 0.4% trypan blue solution. After that, cells were washed again with PBS buffer and 
observed with microscopy.  The blue color shows the dead cells in well plate. This picture is 
shown in the supporting information. 
Preparation of Nanoparticles for Samples 3 and 4. Nanoparticles of the samples 3 and 4 
were prepared by a solvent displacement technique.68 10 mg polymer was dissolved in 1 mL 
of acetone or acetonnitrile. Under magnetic stirring, 0.5 mL of the obtained solution was 
injected with an injection needle (0.6•30 mm) into 5 mL of distilled water at a constant flow 
rate (8.0 mL/min). After the injection, the suspension was stirred for about 2 h under reduced 
pressure to remove the organic solvent. The resulting suspension contained 1 mg/mL polymer 
concentration. 
Preparation of Polyplex with Copolymer. A 5% glucose solution and p-DNA (plasmid-
DNA) for physicochemical-experiments was used for the polyplex formation. 5% glucose is 
an isotonic solution.  In the buffer-solutions, the surface charges of the polymers are reduced 
due to the higher ionic strength, and the polyplexes aggregates to larger agglomerates due to 
the lack of repulsion.62 In terms of dimension, complex formation in a glucose solution is 
most suitable for transfection.27 All solutions were filtered with 0.20 m pore sized filters 
(Nalgener syringe filter, Sigma–Aldrich, Taufkirchen, Germany). 50 L of p-DNA solution 
(40 ng/L) were placed in a micro centrifuge tube. The volume of a 1 mg/mL (based on hy-
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PEI 25 kDa) polymer stock solution (samples 1, 2 and 5-8) or suspension (samples 3, 4) 
required for a certain Nitrogen/Phosphorus-ratio (N/P ratio) was calculated by following 
equation:63 
VDNA = (Ccopolymer × 10 µL × 330) / (CDNA × 157 × N/P)               (3)                               
Ccopolymer = concentration of the stock copolymer 
CDNA = concentration of the stock DNA solution 
A certain amount of polymer stock solution was diluted with buffer-solution to a final volume 
of 50 µL in a micro centrifuge tube. The 50 L polymer aliquots were mixed with 50 µL 
diluted p-DNA aliquots and then incubated for 30 min at room temperature for complexation 
and equilibrium formation. 
Zeta Potential and Size Measurements. The zeta potential and size measurements of the 
polyplexes were monitored with Malvern Zetasizer Nano ZS (Marvern Instrument, 
Worcestershire, UK). The viscosity (0.88 mPa•s) and the refractive index (1.33) of distilled 
water at room temperature (RT) was used for data analysis. The measurement angle was 173° 
in backscatter mode. This polyplex solution was prepared and incubated at RT for 30 min 
before measurement. Subsequently, zeta-potential measurements were performed with the 
same samples after diluting 50 µL of polyplexes with an additional 500 µL of 5% glucose 
solution to a final DNA concentration of 1.82 ng/µL and a final volume of 550 µL. A low 
volume cuvette (100 µL) was used for the size measurements, and the measurements of zeta 
potential were carried out in the standard clear capillary electrophoresis cell at room 
temperature. Three samples were prepared for each N/P ratio, and three measurements were 
performed on each sample. Each measurement of size consisted of 15 runs for 10 sec. Each 
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measurement of zeta potential consisted of 60 runs, which was set to automatic optimization 
by the software. 
Confocal Laser Scanning Microscopy (CLSM). 24 h before of the cell uptake experiment, 
L929-cells were seeded into 8 well-chamberslides (Lab-Tek, Rochester, NY, USA) at a 
seeding density of 50,000 cells/well. in a DMEM low glucose (PAA, Cölbe, Germany) 
medium, which contained 10% fetal calf serum (Cytogen, Sinn, Germany) . Before 
complexation with the copolymer, p-DNA was at first labeled with YOYO-1 (Invitrogen, 
Karlsruhe, Germany) at a weight ratio of 1:15 at room temperature for 30 min in the dark to 
protect fluorescent markers. The YOYO-1 labeled p-DNA was condensed with polymer at 
N/P 15 in a 5% glucose solution, and the polyplexes were incubated for another 20 min at 
room temperature. 25 µL polyplex solution containing 0.5 µg p-DNA and 375 L medium 
with 10% FCS were added in each well. The well-chamberslides were incubated for 4 h at 
37 °C in a humidified 8.5% CO2 atmosphere. After incubation, the cells were washed with a 
0.5 mL PBS buffer and then fixated by 20 min of incubation with 0.1 mL of 4% 
paraformaldehyde in PBS. 30 µL of a 6 µg/mL DAPI solution (Invitrogen, Karlsruhe, 
Germany) was diluted with 1 mL a PBS buffer. Then 100 µL DAPI solutions were filled into 
each chamber for 20 min of incubation in the dark. Afterwards, the cells were washed again 
three times with a 0.5 mL PBS buffer before being fixated with Fluorsafe (Calbiochem, San 
Diego, USA) and covered with a No.1.5 thickness cover slip (Menzel Gläser, Braunschweig, 
Germany). The CLSM measurements were performed with a 385 nm long pass filter and a 
band pass filter of 505-530 nm in the single-track mode (Axiovert 100M and CLDM 510 
Scanning Device; Zeiss, Oberkochen, Germany). The excitation of YOYO-1 labeled DNA 
was performed with a 488 nm argon laser while the excitation of DAPI-stained chromosomal 
DNA was performed with an enterprise laser with an excitation wavelength of 364 nm. 
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In Vitro Transfection. L929 cells were seeded with a density of 30000 cells/mL in 96-well-
plates (Nunc, Wiesbaden, Germany) 24 h before transfection.  Each well contained 6000 cells 
in 0.2 mL medium. The preparation of the polyplex solution was described above. 25 L of 
polyplex solution and 175 L of the medium (10% serum content) were placed in each well 
(0.5 g p-DNA content). The well plates were incubated for 4 h at 37 °C under an 8.5% CO2 
atmosphere. After 44 h, the cell medium was exchanged, and the cells were lysed in a 100 L 
cell culture lysis buffer (Promega, Mannheim, Germany) for 15 min at 37 °C. The 
quantification of lucifaerase activity was determined by injecting a 50 L luciferase assay 
buffer, containing 10 mM luciferin (Sigma-Aldrich, Taufkirchen, Germany), into 25 L of 
cell lysate. The relative light units (RLU) were measured with a plate luminometer 
(LumiSTAR Optima, BMG Labtech GmbH, Offenburg, Germany). The protein concentration 
was determined using a Bradford BCA assay (BioRad, Munich, Germany). The measurement 
of the transfection activity was performed according to the protocol provided by Promega 
(Madison, WI, USA).  
Sybr Gold Assay. The polymer/p-DNA complexes were prepared at N/P = 0.25, 0.5, 1, 2, 4, 
6, 8, 10 in 96 well-plates as described. 200 L dilutions of polymers containing 0.5 g DNA 
for the Syber Gold assay were performed in a water solution. After 20 min of incubation at 
room temperature, 20 L of diluted Sybr Gold solution (5 L stock solution was diluted in 
12.5 mL water) was added to each well and incubated for another 20 min. Sybr Gold is light 
sensitive, and this experiment should be protected from direct light as much as possible. The 
fluorescence was directly detected using a fluorescence plate reader (BMG Labtech, 
Offenburg) at 495 nm excitation and 537 nm emission. Origin 7.0 software was used to draw 
the figure. 
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Heparin Competition Assay. Briefly, polyplexes were prepared in solutions at different N/P-
ratios like the Sybr Gold assay. Additionally, a 20 L Heparin (150 000 IU/g, Serva, Pharm., 
USPXV2, Merck, Darmstadt, Germany) solution with a concentration of 0.5 mg/mL was 
added into a 200L polyplex solution in each well of the 96-well plate (Perkin Elmer, 
Rodgau-Jügesheim), where each well contained 0.5 g p-DNA. After a 20 min incubation of 
the Heparin at 25°C, 20 L of the diluted Sybr Gold solution (Invitrogen, Karlsruhe, Germany) 
were added. The measurement was performed in the same manner as for the Sybr Gold assay. 
Statistical analysis. The statistical analysis was conducted in quadruplicate per group. 
Statistical evaluation was done using the program Sigma Stat 3.5. The One way ANOVA with 
Bonferroni t-test was performed for all the transfection and MTT data.   
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 Results and Discussion 2.2.2
Synthesis. Free radical polymerization of cyclic ketene acetal BMDO and vinyl monomer 
DMAEMA was performed with different monomer ratios in the feed at 70 °C for 24 h. PEO 
macro-azo-initiator with PEO 6 kDa block was used to start the reaction. The molecular 
weight of the PEO azo-initiator was 24 kDa. A schematic illustration of the reaction is given 
in Scheme 1. 
 
 
Scheme 1: Synthesis route for the formation of the poly(PEG-co-(BMDO-co-DMAEMA)) 
and poly(PEG-co-(BMDO-co-DMAEMA))•EtBr. 
The copolymer composition was determined by NMR. In the 1H NMR spectrum, the 
characteristic peaks from both comonomers (BMDO and DMAEMA) and the PEG block 
from initiator were seen.  The peak assignments are given in Figure 15. The signal at 3.6 ppm 
resulted from the PEG block (-OCH2- peak numbers 21, 22 in Figure 15). The 2.2 ppm signal 
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could be assigned to the two methyl groups of DMAEMA (peak 8 in Figure 15). Aromatic 
signals and –OCH2- of BMDO were seen around 7 and 5 ppm, respectively (peaks 5 and 1 in 
Figure 15). In the 13C NMR (not shown here), there was no peak observed around 110 ppm. 
This proved that the complete ring opening mechanism of BMDO formed ester units.65,69 
Peaks 1, 8, 21 and 22 were used to determine the final copolymer composition. Different 
copolymers with varied amounts of ester units could be synthesized by simply changing the 
amount of BMDO in the feed (Table 1). 
 
Figure 15: 1H NMR spectrum of the copolymer p(PEG-co-poly(BMDO-co-DMAEMA)) with 
4 mol% BMDO in the feed (Sample 2, Table 1). 
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Table 1: Synthesis of the p(PEG-co-poly(BMDO-co-DMAEMA))  copolymers with PEO 
macro-azo-initiator at 70 °C for 24  h. 
Sample Name
 
 
Feed ratio 
molar ratio 
BMDO:DMAEMA 
Poylmer composition 
molar ratio 
BMDO:DMAEMA 
 
Yield 
[%] 
 
Solubility 
maximum 
[mg/mL] 
1a 0 : 100 0 : 100 43 2.1 (water) b 
2 10 : 90 4 : 96 70 2.0 (water) b 
3 50 : 50 16: 84 45 0.5 (water) b 
4 90 : 10 45: 55 32 280 (acetonitile)
a This reaction was carried out for 50 min; b under ultrasound. 
The presence of PEG blocks from the initiator in the polymer chains increased the 
hydrophilicity of these new copolymers and showed an improvement in the solubility 
behavior in water. In our previous work, the random copolymer poly(BMDO-co-DMAEMA) 
showed limitations for use as a gene transfection system due to insolubility in water and water 
miscible solvents like acetonitrile.61 The quantitative data are shown in Table 1 and Table 2. 
The use of a PEO macro-azo-initiator led to improved solubility of all of the copolymers both 
in water and acetonitrile, even with high amounts of BMDO (Table 1).  
The copolymers (Samples 1-4; Table 1) were further quaternized with ethylbromide via SN2 
substitution. The properties of quaternized polymers are tabulated in the Table 2. After 
quaternization, the solubility of the copolymer was further improved significantly. All 
copolymers (even the polymer with BMDO: DMAEMA 45 : 55 molar ratio) could be solved 
in water immediately. 
 Chapter  II: Degradable Polymers for DNA Transfection 
 
 
37 
 
Table 2: Quaternization reaction of the p(PEG-co-(BMDO-co-DMAEMA)) with ethyl 
bromide at 45 °C for 40 h. 
Sample 
Name 
(quaternized) 
 
Copoylmer 
composition 
molar ratio 
BMDO:DMAEMA 
Reactant 
sample 
Quaternization 
Yield 
[%] 
Mn Mwa Solubility 
[kDa] 
 Max. 
[mg/mL] 
5 0 : 100 
 
 
1 100 54 322 320 
(water) 
6 4 : 96 2 100 46 127 300 
(water) 
7 16 : 84 3 100 26 67 220 
(water) 
8 45 : 55 4 92 13 36 200 
(water) 
a
 Mn, Mw were determined with water GPC. 
The 1H NMR spectrum after the quaternization reaction showed the shifting of peaks 8 and 9 
to a lower magnetic field (Figure 16). The addition of the ethyl groups (-CH2-) and –CH3 
protons 23, 24 in Figure 16) was also observed at a high magnetic field. The degree of 
quaternization was calculated using the integrals of the two methyl groups on the nitrogen 
atom of DMAEMA. The quaternization reaction for most of the polymers was quantitative 
(Table 2). The molecular weight and yield of the copolymer decreased with the increase of 
BMDO content. The copolymers showed molecular weights between 13 kDa and 60 kDa. The 
polydispersity of the polymers was high. This could be due to the formation of  different 
multiblock copolymers with PEG block and block of a copolymer of BMDO-co-DMAEMA 
or amphiphilic nature of the block copolymers. Poly(PEG-co-(BMDO-co-DMAEMA•EtBr)) 
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copolymer contained a hydrophilic part, PEO, a hydrophobic part, BMDO, and the positivly 
charged PDMAEMA-EtBr. This combination is a challenge for the column system and could 
lead to broad signal. 
 
   
Figure 16: Comparison of NMRs of sample 3 and sample 7 (molar ratio of 
DMAEMA:BMDO is 15:85) before and after quaternization reaction.  
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Figure 17: 1H NMR spectrum in CDCl3 before and after hydrolysis of poly(PEG-co-(BMDO-
co-DMAEMA)) (sample 4): a) before hydrolysis of the copolymer with molar ratio of 
BMDO:DMAEMA = 45:55; b) after 24 h hydrolysis in 5 wt.%  KOH solution; c) after 48 h 
hydrolysis in 5 wt.% KOH solution. 
Degradability Study. The hydrolytic degradation behavior of the new copolymers was 
studied under basic (pH = 9), physiological (pH = 7.4) and enzymatic conditions. The 
degradation rate was determined by comparing peak integrals before and after hydrolysis as 
shown for sample 4 (Figure 17). Proton 1 at 5 ppm showed the characteristic proton peak in 
proximity to the ester bond of BMDO units. In Figure 17, the reduced intensity of the proton 1 
signal after 24 h degradation could be observed. After 24 h, around 65% and after 48 h, nearly 
93% of the ester bond was hydrolyzed. 
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Figure 18:  GPC overlays of poly(PEG-co-(BMDO-co-DMAEMA)) (sample 7, mol ratio of  
BMDO:DMAEMA = 16:84) a) GPC result before basic hydrolysis; b) after 24 h of basic 
hydrolytic degradation with 5 wt.% KOH; c) after 48 h of basic hydrolytic degradation with 
5 wt.% KOH; d) after 160 h degradation with 10 mg/mL Lipase (from Pseudomonas cepacia) 
solution. e) after 160 h degradation with phosphate buffered saline (PBS) (0.1M, pH 7.4) 
 
For the quaternized polymer (samples 5-8), the decrease of molecular weight could be 
observed directly via GPC. The molecular weight of the basic and enzymatic degradation 
products of sample 7 are shown in Figure 18. The overlay of the GPC results showed a shift in 
the retention volume. After 24 h of basic hydrolysis, the synthesized block copolymer was 
completely degraded to the low molecular weight range, which was already in the exclusion 
volume of the column. A significant signal in the oligomer range around 6 kDa was seen. This 
was the molecular weight of the PEG block left over after degradation. The SEC results 
showed also a clear shift to the small molecular range after 160 h degradation with both an 
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enzyme (Lipase from Pseudomonas cepacia) and PBS buffer at 37 °C. The molecular weight 
of the degradation product under PBS buffer condition is slightly higher than under the 
enzymatic condition. A bimodal molecular curve was obtained after degradation. Because of 
the bimodality of the GPC curve, the Mp value of the curve was determined for comparison. 
The higher Mp is around 6500 g/mol. This also showed the molecular weight of the PEG 
block. The smaller molecular weight is already out of the resolution range of the column. 
Sample 7 had the least ester content and could still be rapidly degraded to oligomers because 
of the random addition of BMDO in the polymer. 
Cytotoxicity Test Using MTT Assay. The cytotoxicity of all of the synthesized copolymers 
was tested using L929 cells. The cell viability of the synthesized copolymer was compared 
with a PEI 25 kDa as the standard. A polymer concentration between 0.01 mg/mL and 
1 mg/mL was tested. The cell viability is shown logarithmically (Figure 19, A). The IC50 
values are shown in a bar diagram (Figure 19, B). The statistical analysis shows the 
“probability of obtaining a test statistic” (P value) to be smaller than 0.001. Sample 4 shows 
the highest cell viability so we compared all the MTT result with sample 4. The statistical 
analysis shows also a small p value, smaller than 0.001. All of the synthesized copolymers 
have higher IC50 values than PEI 25 kDa, especially the unquaternized copolymers (samples 
1-4). For example, sample 4 showed an IC50 value of 0.18 mg/mL, which was 22 times higher 
than PEI 25 kDa. All of the quaternized copolymers (samples 5-8) have higher cell viability 
than the unquaternized copolymers because of the more positively charged surface.  Sample 8 
showed an IC50 value of 0.12 mg/mL, which was 15 times higher than PEI 25 kDa.  
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Figure 19:  A) Cytotoxicity of polymer study by MTT assay. L929 cells were incubated with 
polymers of different composition for 24 h; B) IC50 doses for different poly(PEG-co-(BMDO-
co-DMAEMA) polymers and the standard PEI 25kDa.*** means a P value smaller than 0.001. 
The micrographs showed the cell morphology comparison after 4 h and 24 h treatment with 
0.03 mg/mL of the polymer samples 6-8 and PEI 25 kDa (Figure 20). The micrographs of the 
L929 cells demonstrate the higher viability of the cells treated with the BMDO copolymer as 
opposed to those treated with PEI. Sample 6 (pictures a and e) and PEI 25 kDa (pictures d and 
h) showed comparable cell morphology, while samples 7 and 8 showed higher cell density 
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and viability. After 20 further hours of incubation, the viability in all cases decreased, but the 
differences between samples 7 and 8 as opposed to samples 6 and PEI remained. Whereas for 
sample 6 and the PEI 25kDa, the cell viability was almost zero after 24 h, sample 7 showed a 
reduced viability and sample 8 showed a minimal decrease in viability. All of these results 
clearly show significantly reduced toxicity of the polymers compared to the accepted gold 
standard PEI 25kDa. 
 
Figure 20: 40×Micrographs of the L929 cells, which were incubated with polymers for 4 h 
and 24h, respectively. The concentration of the polymers was 0.03 mg/mL. a) with sample 6 
for 4 h; b)  with sample 7 for 4 h; c) with sample 8 for 4 h; d) with PEI 25 kDa for 4 h; e) with 
sample 6 for 24 h; f) with sample 7 for 24 h; c) with sample 8 for 24 h; d) with PEI 25 kDa for 
24 h. 
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Quantitative data of MTT assay for 4 h polymer treatment as a percentage curve are shown in 
supporting information. To assess the cell viability qualitatively, we also used 0.4% trypan 
blue solution to stain died cells. The same result could be observed like using bright field 
microscope. This experiment results are showing in the supporting information. 
Zeta Potential and Size Measurements. The hydrodynamic diameters of the polymer with a 
p-DNA complex at different N/P ratio were measured at room temperature (Figure 21). This 
size measurement was performed for all of the stable polyplexes at N/P ratios between 0 and 
20. It has been reported that the acceptable size of polyplex for endocytosis are less than 250 
nm.70,71 
The polydispersities of the polyplexes were all smaller than 0.3. All of the polyplex sizes were 
less than 250 nm, and had already reached this size at an N/P ratio of 5. The size of the 
polyplex depends on the N/P ratios and the polymer composition. With the increase of the 
N/P ratio, the polyplex size decreased. With the increase of the PEG and BMDO part, the 
polyplex size decreased as expected. That can be explained by the shielding effect of PEG.70 
According to the hydrodynamic size of the polyplexes, these copolymers are suitable 
candidates for gene transfections. 
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Figure 21: Size of polyplexes formed with plasmid DNA (samples 1-8) at different N/P ratios 
by DLS (dynamic light scattering) measurement. 
 
Figure 22: The zeta potential of polyplexes (samples 1-8 with plasmid DNA) at different N/P 
ratios. Values are the means of 6 runs. 
The zeta potential of the polyplex was determined at the N/P ratios of 5, 10, and 20 
(Figure 22). The zeta potential increased with the increasing N/P ratio. The polyplex with 
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quaternized polymer poly(PEG-co-(BMDO-co-DMAEMA))•EtBr showed higher zeta 
potential than the unquaternized polymer poly(PEG-co-(BMDO-co-DMAEMA)). All of the 
p-DNA polyplexes had positive surface charges which are considered to facilitate uptake by 
negatively charged cell membranes.71,72 
Confocal Laser Scanning Microscopy (CLSM). To observe the cell uptake differences 
between unquaternized polymers and quaternized  polymers, the unquaternized/quaternized 
pair: sample 3 and sample7 was used for CLSM. CLSM images of the L929 cells incubated 
with fluorescence labeled copolymer p(PEO-co-(BMDO-co-DMAEMA)) DNA complexes 
for 4 h are shown in Figure 23. The CLSM graph showed obviously cell uptake of these two 
polymers not only into the cell cytosol, but also into the cell nucleus. But compared with 
unquaternized sample 3, quaternized sample 7 showed meanwhile higher cytotoxicity because 
of the higher surface charges. Therefore, we assumed that the quaternized polymers can 
condense the p-DNA very well but the transfection efficiency of these polymers was still 
limited because they were too toxic. On the other hand, the interaction between p-DNA and 
quaternized polymers was too strong and it was therefore difficult for the quaternized 
polymers to release the p-DNA in the cell nucleus. 
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Figure 23: Cell uptake study using CLSM with L929 cells for A: sample 3 and B: sample 7. 
Plasmid DNA were labeled with YOYO-1 (green); cell nucleus were labeled with DAPI 
(blue). The cells were incubated with pDNA/p(PEG-co-(BMDO-co-DMAEMA)) complexes 
at N/P ratio 10 for 4 h. The sample 3 showed significantly cell uptake of complexes into the 
cell nucleus and also the cell cytosol; the quaternized sample 7 showed obviously cytotoxicity, 
although the cell uptake of complexes into the cell nucleus was also observed.  
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In Vitro Transfection. Transfection experiments with plasmid-DNA were performed with all 
the DMAEMA based polymers (samples 1-8) (Figure 24). PEI 25kDa was used as the positive 
control for this experiment. First we compared the synthesized polymer transfection effiency 
with PEI 25kDa. Then we compared the transfection effiency at N/P 5 for all the samples. The 
statistical analysis for the unquaternized polymers shows the P value to be smaller than 0.01, 
which indicated a relative good test results. 
All of the unquaternized polymers (samples 1-4) showed successful transfection and the same 
tendency. The p-DNA transfection efficiency increased with the increasing of N/P ratio until a 
best N/P ratio and decreased after the best transfection efficiency was reached. At N/P 1, 
almost no polymers showed significant transfection, even PEI 25kDa, because at N/P 1, the p-
DNA could not be condensed completely within the polycations. Surprisingly, sample 2 with 
the 4% BMDO began to show low transfection while the other polymers were silent. Samples 
1 and 2 have the advantage of a higher DEMAEMA concentration and, therefore, the higher 
density of positive charges for condensing the negatively charged p-DNA. Compared to 
samples 3 and 4, they showed a better transfection in the luciferase experiment. However, 
sample 1 only showed a good transfection efficiency at a higher N/P 20 because the 
polyplexes of this polymer with p-DNA were larger than the others and the size was only less 
than 230 nm if the N/P ratio was over 10. Compared to samples 1, 2 and 4, sample 3 showed 
the best transfection at N/P 5, which is a standard for animal testing, at which the polymers 
were not yet so toxic. The particle size of the polyplex with sample 3 was also relatively low 
and was even under 120 nm at N/P 5. Additionally, sample 3 had a lower surface charge than 
samples 1 and 2, which offers a long term circulation in the blood in the in vivo experiment. 
The ester bond in BMDO could be degraded under basic and enzymatic condition. Sample 3 
had a higher BMDO content than samples 1 or 2, which means more potential 
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biodegradability than sample 1 or 2. Therefore, although the in vitro luciferase assay showed 
no greater p-DNA transfection efficiency with sample 3 than samples 1 and 2, we believe that 
sample 3 will be a highly potent gene delivery agent. 
 
Figure 24: Transfection result of plasmid-DNA-polymer-complexes with L929 cells at 
different N/P ratio. ***means a P value smaller than 0.001, ** means a P value smaller than 
0.01. 
It is known that the molecular weight, rigidity and charge density of the pDMAEMA 
influence the transfection efficiency.73 . All of these physical properties could be regulated to 
balance the protection and release of the DNA. Among these factors, the stability of 
polyplexes was believed to play a more important role than others.74  The stability of the 
polyplex is dependent on the charge density of the polymer. Because the polyplexes of 
plasmid DNA were formed via electrostatic interaction between polymer and plasmid, the 
polymer with relative high positive charge density can condense the plasmid into more stable 
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complex with positive charged surface. 
The CLSM result showed that all of the quaternized copolymer polyplexes (samples 6-8) 
reached the cell nucleus. The cytotoxicity of the quaternized polymers was higher than the 
unquaternized polymer due to the higher density of the positive charges on the polymer 
surface. A high density of positive charges on the polymer surface may cause very strong 
electrostatic interactions, which may lead to polyplexes that are too stable to release plasmid 
DNA into the cytosol or into the cell nucleus, therefore no expression of the target gene could 
be observed. That could be the reason for the completely negative transfection results for the 
quaternized polymer samples. The quaternized samples had a much higher charge density 
than the unquaternized samples. That led to a much more stable complex with DNA and 
higher toxicity of the polymers. To analyze the stability of the polyplexes, a further Sybr Gold 
and Heparin competition assay was performed. 
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Sybr Gold and Heparin Competition Assay.  
 
Figure 25: Complexation behavior of p(PEG-co-(BMDO-co-DMAEMA) (samples 1-8) 
measured by Sybr Gold intercalation of residual free plasmid DNA increaseing N/P ratio. 
 
Figure 26: Release profiles of plasmid DNA from polyplex of samples 1-8 by increasing N/P 
ratio.  
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The Sybr Gold assay showed the different condensation abilities of the polymers with 
plasmid-DNA. The affinity of plasmid-DNA with a polymer was increased by increasing the 
DEMAEMA content, and plasmid DNA could be condensed very well from N/P 6 with all of 
the quaternized polymers (samples 5, 6, 7, 8) (Figure 25). Compared to the quaternized 
polymer, the condensation ability with plasmid DNA of the unquaternized polymers was 
lower. However, sample 1 also showed good condensation with plasmid DNA up to N/P = 6 
because of the high DEMAEMA content, although it was unquaternized and had a less 
positive surface charge. The other unquaternized polymers (samples 2, 3, 4) could not 
completely reach a complete p-DNA condensation with an increasing N/P ratio, especially 
sample 4. The stability of polyplexes against competing polyanions is also an important 
parameter for a gene delivery system, especially for in vivo experiment, because the stability 
of the polyplexes can be strongly weakened by the presence of serum in blood.75 The process 
of gene material complexation within polycations is entropy driven and can be significantly 
impaired by the presence of other polyions like Heparin.76 Differences in the stability against 
polyions were found to follow the same trend as the Sybr Gold assay, but the polyplexes 
formed with quaternized copolymers were less impaired by Heparin (Figure 26). That means 
the condensation of the plasmid DNA with quaternized copolymers was complete. The 
plasmid DNA was very difficult to be released if delivered into the nuclei. Therefore, no 
successful transfection was observed in the in vitro transfection experiment for the 
quaternized polymers, in contrast to the successful transfection with unquaternized polymers 
(Figure 27). 
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Figure 27: In vitro pDNA transfection mechanism with the synthesized polymer p(PEG-co-
(BMDO-co-DMAEMA) (samples 1-4) and p(PEG-co-(BMDO-co-DMAEMA)•EtBr (samples 
5-8). 
 
 Conclusion 2.2.3
Novel degradable and biocompatible poly(PEG-co-(BMDO-co-DMAEMA) for gene 
transfection were successfully synthesized via free radical polymerization. The solubility and 
the IC50 values of the copolymers were significantly improved by bringing hydrophilic PEG 
blocks into the polymer backbone. The toxicity of all the polymers was much lower than the 
positive control PEI. The unquaternized copolymers showed a higher cell viability than the 
quaternized copolymers as well as positive results in p-DNA transfection. 
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2.3 MDO based Polymers for DNA Transfection 
This work was done in cooperation with prof. Dr. Achim Aigner. Transfection studies were 
carried out in his laboratory. 
 Experimental Part 2.3.1
Materials. PEO macro-azo-initiator (Mp = 24 kDa, PEG block = 6 kDa g/mol and PEG block 
2 kDa g/mol) was purchased from WAKO Chemicals (Neuss, Germany). N,N-
dimethylaminoethyl methacrylate (DMAEMA) (Acros Organics / Fisher Scientific, Nidderau, 
Germany) was destabilized by removing the inhibitor through a basic alumina column to 
remove the inhibitor. Bromoethane (99%; Acros Organics / Fisher Scientific) was used as 
received. DMF, chloroform, pentane and methanol were purchased from BASF 
(Ludwigshafen, Germany) and distilled prior to use. MDO was synthesized according to our 
previous report.12,69 
The ovarian carcinoma cell line SKOV-3 was purchased from ATCC/LGC Promochem 
(Wesel, Germany). The luciferase plasmid (pGL3 control) was obtained from Promega 
(Mannheim, Germany), and the luciferase plasmid (pCMV-Luc) (Lot No.: PF461-090623) 
was ordered from The Plasmid Factory (Bielefeld, Germany). 
Instrumentation. One dimension NMR 1H (400, 13 MHz) and 13C (100, 21 MHz) spectra 
were recorded on a Bruker DRX-400 spectrometer. Tetramethylsilane was used as internal 
standard.  
For the elementary analysis (CHN), the polymer was burnt in an excess of oxygen. The 
corresponding products water (H2O), carbon dioxide (CO2) and nitric oxide (NO) were 
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collected and weighted. From the weight of the corresponding products the composition of 
CHN of the sample could be calculated.  
For bromine analysis, Schoendinger oxidation was performed, followed by the titration with 
silver nitrate (AgNO3). The measurement of the weight of AgBr allows the calculation of the 
bromine content in the corresponding sample.  
Thermo gravimetric (TGA) measurements were done on a TGA/SDTA 851e (Mettler Toledo). 
Differential scanning calorimetry (DSC) measurements were performed on a DSC 821e unit 
(Mettler Toledo). 8-15 mg of the sample were heated in an alumina crucible with a rate of 5 
K/min. The temperature program consisted of two heating and cooling cycles from -100 °C to 
250 °C. 
For the good water soluble samples, the molecular weight and the polydispersity of the 
synthesized polymers were measured by size exclusion chromatography at 25 °C, using a 
linear PSS suprema Max 1000 Å column, a differential refractive index detector (SEC curity 
RI, PSS) and a SECcurity 1100 (PSS) pump. 0.3 mol/L  formic acid water solvent was used as 
eluent at a flow rate of 0.5 mL/min. Linear polyvinylpyridin was used as standard for 
calibration. The inject volume of the GPC system was 100 L and the polymer concentration 
was 1 mg/mL. Ethylene glycol served as internal standard. 
Sample T7, which showed limited solubility in water, was measured with DMF LiBr GPC. 
The DMF GPC was measured at 25 °C with a 50 × 8 mm2 pre-column and three linear 10 m 
polyester columns (GRAM, PSS) 300 × 8 mm2. The inject volume was 50 L and the polymer 
concentration was 1 mg/mL. An RI Detector 2300 (KNAUER) and a pump (AGILENT) 
system was used in this system. Destilled DMF containing 5 g/L LiBr served as eluent at a 
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flow rate of 1 mL/min. PMMA was used for calibration, and toluene served as internal 
standard. 
Copolymerization of MDO and DMAEMA with PEO Macro Initiator. As an example for 
polymerization reactions, the conditions for sample T3 are described as follows: The 
monomer MDO (3.5 mL, 31 mmol) and DMAEMA (0.57 mL, 3.3 mmol) were filled in a pre-
dried Schlenk tube with a magnetic stir bar under argon atmosphere. This reaction mix was 
degassed by three freeze-pump-thaw cycles. The PEO macro-azo-initiator with PEG 2000 
block (0.69 g, 1 mol-%) was added to the still frozen reaction mixture. The Schlenk tube was 
evacuated and backfilled with Argon three times. This reaction mixture was placed 
immediately in a preheated oil bath on a magnet heater at 70 °C for 24 h. Subsequently, the 
Schlenk tube was taken out of the oil bath and fast cooled in an ice bath. The reaction mixture 
was diluted with CHCl3 and precipitated in 200 mL cold pentane, yielding a pale yellow 
precipitate. This pale yellow polymer was washed with a small amount of water and then 
dissolved in chloroform and precipitated in pentane again. This procedure was repeated twice, 
and the product was then further purified by dialysis against water. The final polymer product 
was dried under vacuum at 40 °C for 48 h. 
The polymer structure was determined by NMR spectroscopy. Details on the feed ratio, the 
composition of the copolymers with regard to the monomers and the corresponding 
copolymer names are given in Table 3.  
Quaternization Reactions with EtBr. 500 mg copolymer (T1-T3, S1-S3) were dissolved in 
40 mL chloroform at room temperature in a round bottom flask with a magnetic stir bar. 
Ethane bromide was used as quaternization reagent.61 1.5 mL methanol and 5 mL ethane 
bromide (excess) were added to the reaction mixture. The flask was placed in a preheated oil 
bath at 45 °C and stirred for 40 h. Afterwards, most of the solvent was evaporated in a rotary 
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evaporator at 45 °C. The residue was dissolved again in 3 mL methanol and precipitated in 
cold pentane. This product was purified by repetitive solving in methanol and precipitating in 
pentane twice. The final polymer was dried at 40 °C under vacuum for 48 h. 
Hydrolytic Degradability. In general, 100 mg the polymer was dissolved in a flask 
containing 15 mL of 5 wt.% KOH in distilled water on a magnetic stirrer. After stirring of the 
mixture at room temperature for 24 h, 10 mL 10 wt.% HCl was added for neutralization, prior 
to extraction of this neutral mixture with chloroform. The chloroform phase was dried under 
vacuum for 3 days. The molecular weight of the remaining solid was than characterized by 
GPC measurement. 
Preparation of Polyplexes from the Copolymers. Complexes were prepared in ddH2O at 
various polymer/nucleic acid mass ratios, as indicated in the figures. To this end, 10 mg/ml 
polymer stock solutions in 1:1 acetonitrile / ddH2O (S1 - S3, T1 - T3) or in ddH2O (S5 - S7, 
T5 - T7) were prepared. The polymer solution was pipetted directly into a 0.1 mg/ml DNA 
stock solution in water, and ddH2O was added to adjust to the final complexation volume 
(30 µl, 60 µl or 90 µl for the complexation of 1 µg, 2 µg or 3 µg DNA, respectively), mixed 
briefly, incubated for 30 min at room temperature, and briefly vortexed again directly prior to 
use. 
Size Measurement and Zeta Potential Measurement. The zeta-potential and the average 
particle sizes of the polyplexes obtained at different N/P ratios were determined by dynamic 
light scattering using a Malvern Zetasizer Nano ZS (Malvern Instruments, Worcestershire, 
UK). The viscosity (0.88 mPa•s) and the refractive index (1.33) of destilled water at room 
temperature (RT) was determined and used as reference. The measurement angle was 173° in 
backscatter mode. The polyplex solution was incubated at room temperature for 30 minutes 
prior to measurement in a low volume cuvette (100 L). Three samples were prepared for 
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each polymer/DNA ratio and three measurements were performed on each sample. Each 
measurement of size was performed for 15 runs at 10 sec each. The particle mean diameter 
(Z-Ave) and the width of the fitted Gaussian distribution were calculated with the DTS V. 
5.10 software. Each measurement of zeta-potential consisted of 60 runs, which was set to 
automatic optimization by the software. Again, the DTS V. 5.10 software was used to 
calculate the average z-potential values from the data of multiple runs. 
Determination of DNA Complexation Efficacy. To determine the efficacy of polymer/DNA 
complex formation, DNA was [32P]-labeled using the ReadyPrime kit from Amersham 
(Freiburg, Germany) according to the manufacturer's protocol, with 25 ng DNA and 50 µCi 
α-[32P]dCTP. Purification was performed using Micro Bio-Spin Chromatography Columns 
(BioRad Laboratories, CA) by applying the solution onto pre-centrifuged (2 min, 1,000 x g) 
P-6 columns and subsequent centrifugation at 1,000 x g for 4 min for recovering the labelled 
nucleic acids in the flowthrough. Prior to complexation, the labeled DNA was mixed with 25 
µg unlabeled DNA. The complexation was performed as described above, with 200 ng DNA 
per complex and polymer/DNA mass ratios as indicated in the figure (0.001 - 1000). Samples 
were then mixed with loading buffer, and loaded onto 1% agarose gels. Electrophoresis was 
performed at 100 mV for 1 h, and DNA bands were analysed by autoradiography in a Cyclone 
Plus Phosphoimager (Perkin-Elmer, Fremont, CA). Percentages of nucleic acid complexation 
were calculated based on the quantity of free DNA relative to completely complexed (100%) 
samples. 
Determination of Transfection Efficacy and Cytotoxicity. For transfection experiments, 
cells were cultivated in IMDM medium (PAA, Cölbe, Germany) supplemented with 10 % 
fetal calf serum (Gibco / Life Technologies, Darmstadt, Germany) under standard conditions 
(37°C, 5% CO2 in a humid atmosphere). DNA transfection was performed in serum-
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containing medium (IMDM/10% FCS), essentially as described previously.77 Briefly, cells 
were seeded at 4 x 104 cells/well in 24-well plates, and after 1 d cultivation in serum-
containing medium, polymer/DNA complexes prepared as described above were added at the 
amounts detailed in the figures. Luciferase activity was determined 48 h after DNA 
transfection, using the luciferase assay kit from Promega (Mannheim, Germany) according to 
the manufacturer’s protocol. Briefly, the medium was aspirated and the cells were lysed in 
100 µl lysis buffer. In a luminometer tube, 25 µl substrate was mixed with 10 µl lysate, and 
chemiluminescence was determined immediately in a luminometer (Berthold, Bad Wildbad, 
Germany). 
Cell viabilities in the presence of the polymers were determined as described previously.61 
Briefly, cells were seeded in 96-well plates at 2000 cells/well and treated with a polymer at 
the concentration indicated in the figure. Numbers of viable cells were determined using a 
colorimetric assay, which is based on the cleavage of the tetrazolium salt WST-1 by 
mitochondrial dehydrogenases, according to the manufacturer’s protocol (Cell Proliferation 
Reagent WST-1, Roche Molecular Biochemicals, Basel) with each value representing the 
mean of triplicate wells. 
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 Results and Discussion 2.3.2
Synthesis and Characterization of P(PEG-co-(MDO-co-DMAEMA)) 
 
Scheme 2: Synthesis route for the poly(PEG-co-(MDO-co-DMAEMA)) and poly(PEG-co-
(BMDO-co-DMAEMA))•EtBr. 
 
First, the monomer MDO was synthesized through a previously reported three step reaction 
method.12,78 A free radical polymerization of MDO and DMAEMA was performed with two 
kinds of PEO macro-azo-initiators, one with PEG 2 kDa block length and the other one with 
PEG 6 kDa block length. Both kinds of PEO macro-azo-initiators have a molecular weight of 
24 kDa and contain PEG blocks which are connected with azo groups (Scheme 2). As set of 
p(PEG-co-(MDO-co-DMAEMA)) copolymers with different monomer ratios was synthesized. 
Copolymer names and reaction details are shown in Table 3. 
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Table 3: Details and properties of the various p(PEG-co-poly(MDO-co-DMAEMA)) 
copolymers synthesized with PEO macro-azo-initiator at 70 °C for 24  h. Copolymers T1-T4 
contain PEG 2000 blocks, copolymers S1-S4 contain PEG 6000 blocks. 
 
Copolymer 
name 
Feed ratio 
molar ratio 
MDO:DMAEMA 
Composition 
mol% 
MDO:DMAEMA 
Yield 
% 
Soluble 
in 
T1 0:100 0:100 80 Acetonnitrile 
T2 50:50 10:90 66 Acetonintrile 
T3 90:10 57:43 59 Acetone 
T4 100:0 100:0 50 CHCl3 
S1 0:100 0:100 68 H2O 
S2 50:50 22:78 62 Acetonnitrile 
S3 90:10 51:49 52 Acetone 
S4 100:0 100:0 40 CHCl3 
  
The structural characterization of the polymers was done by NMR spectroscopy. A 
representative 1H NMR spectrum of the polymer product (T3) with 57 mol-% of MDO in the 
initial feed (Sample T3, Table 3) is shown in Figure 28, and a comparison of copolymers with 
various MDO:DMAEMA ratios is presented in Figure 29.  
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Figure 28: 1H NMR spectrum of copolymer p(PEG-co-poly(MDO-co-DMAEMA)) with 
90 mol-% MDO in the feed ratio (copolymer T3; see Table 3).  
 
 
Figure 29: 1H NMR spectrum overlay of various p(PEG-co-poly(MDO-co-DMAEMA)) 
copolymers (T1-T4; see Table 3).  
The solubility of the polymer in water and water miscible solvents determines the conditions 
of polyplex formation with DNA. The addition of PEG blocks in the copolymer increased the 
solubility of the polymer in water or water miscible solvents. The solubility was better for 
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polymers made with PEG 6 kDa initiator (samples S1-S4) as compared to the polymers made 
with PEG 2 kDa (T1-T4), and decreased with higher MDO content (Table 3).  
To improve the solubility and increase the charge density of the polymers, a quaternization 
reaction of nitrogen atoms was performed with EtBr at 45 °C for 40 h. The sample names, 
molecular weights and solubilities of the polymers are shown in Table 4. The quaternization 
ratio was determined by a 1H NMR method (Figure 30). After 40 h, more than 90% of the 
nitrogen in the polymer was quaternized. All the obtained quaternized cationic polymers 
containing DMAEMA were water soluble. A further increase in water solubility was observed 
with decreasing MDO amounts in the composition and higher PEG block length. Sample T7 
was soluble in water after ultrasound treatment for 5 minutes. 
Table 4: Details and properties of the various quaternized p(PEG-co-poly(MDO-co-
DMAEMA)) copolymers (quaternization performed with ethyl bromide at 45 °C for 40 h). 
 
Quaternized  
copolymer 
name 
Composition 
mol% 
MDO:DMAEMA 
Educt 
sample 
name 
Yield 
% 
Soluble 
in 
Mn 
kDa 
Mw 
kDa 
T5 0:100 T1 95 H2O 31 104 
T6 10:90 T2 92 H2O 25 110 
T7 57:43 T3 90 H2Oa) 12b) 24b) 
- 100:0 T4 - CHCl3 11 34 
S5 0:100 S1 93 H2O 58 145 
S6 22:78 S2 91 H2O 55 150 
S7 51:49 S3 95 H2O 23 80 
- 100:0 S4 - CHCl3 3 9 
a)soluble under ultrasound; b)measured with DMF LiBr GPC. 
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Figure 30: Comparison of NMR spectra of copolymer T2 and its quaternized counterpart 
(copolymer T6).  
 
The unquaternized block copolymers (T1-T3, S1-S3) were stable up to about 250 °C, as 
determined by thermo gravimetric analysis. The differential scanning calorimetric 
thermogram for the PEO macro-azo-initiator showed a single melting peak at 42 °C. The 
second heating cycle of the synthesized polymers is shown in Figure 31. For the MDO-
containing copolymers, a melting peak at around 50 °C was determined. These polymers 
showed different crystallinity, dependent on the PEO macro-azo-initiator length. An increase 
in the area under the melting peak (melting enthalpy) was obtained with the higher PEG block 
length in the copolymer composition. More specifically, copolymers with PEG 2000 block as 
initiator (T2, T3, T4) showed a melting enthalpy smaller than 30 J/g, while for copolymers 
with PEG 6000 block as initiator (S2, S3, S4) melting enthalpies higher than 30 J/g were 
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determined. The percentage of crystallinity was calculated based on the known melting 
enthalpy of 100% crystalline PEG (189 J/g 79). Only samples with PEG 2000 block (T2, T3, 
T4) showed Tg (glass transition temperature) in the second heating cycle. The glass transition 
temperature of copolymers increased with decreasing amounts of DMAEMA in the 
copolymers 50oC, 55oC and 60oC for the samples T2, T3 and T4, respectively.80  
 
 
 
Figure 31: Differential scanning calorimetry (DSC) thermograms of the various p(PEG-co-
(MDO-co-DMAEMA)) copolymers (second heating cycle of the unquaternized copolymers 
T2-T4, S2-S4). 
 
The hydrolytic degradation behavior of the polymers was analyzed at basic pH, with the 
decrease of the polymer molecular weight being monitored via GPC. As a representative 
example, the molecular weight of sample T6 before and after degradation is shown in Figure 
32. The overlay of the GPC results shows the difference in the retention volumes, indicating 
that polymer T2 was completely degraded from 25 kDa down to the PEG blocks and small 
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molecules. Comparable to T6, all MDO-containing polymers showed complete degradation 
under these conditions (data not shown).  
 
 
 
Figure 32: GPC overlays of poly(PEG-co-(MDO-co-DMAEMA)) (copolymer T6, mol ratio 
of  MDO:DMAEMA = 10:90) a) GPC result before basic hydrolysis; b) after 24 h of basic 
hydrolytic degradation with 5 wt.% KOH. 
 
Upon complexation of DNA, zetasizer measurements revealed that the sizes of all polyplexes 
were below 250 nm, and the PDI values were < 0.3. For any given polymer, the polyplex size 
decreased with increasing polymer/DNA ratios (Figure 33). Also, p(PEG-co-(MDO-co-
DMAEMA)) copolymers resulted in somewhat smaller complexes after quaternization of the 
nitrogen atoms (compare e.g. samples T1 vs. T5; S1 vs. S5). Apart from these trends, no 
major size differences were observed, with all complexes being well in the size range of 
cellular internalization. Likewise, the zeta potentials of all the synthesized polymer complexes 
were positive even at the lowest polymer/DNA mass ratio (Figure 34), and thus in the range 
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necessary for cellular uptake.71,72 As expected, zeta potentials increased with higher 
polymer/DNA mass ratios, and there was a trend towards higher zeta potentials in the 
complexes based on quaternized polymers when compared to their unquaternized counterparts 
(compare T1-T3 with T5-T7; S1-S3 with S5-S7). Likewise, there was a trend towards higher 
zeta potentials in complexes based on polymers with PEG 6 kDa blocks as compared to their 
PEG 2 kDa block counterparts (compare T1-T3 vs. S1-S3; T5-T7 vs. S5-S7). 
 
Figure 33: Size of polyplexes, formed with the various copolymers and plasmid DNA at 
different polymer/DNA ratios, as determined by dynamic light scattering (DLS) measurement. 
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Figure 34: Zeta potential of polyplexes, formed with the various copolymers and plasmid 
DNA at different polymer/DNA ratios. Values are the means of 6 runs. 
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Complexation efficiency with DNA. The complexation efficiency with DNA is one crucial 
property for gene delivery vectors, since complete complex formation is an essential pre-
requisite for cellular uptake. DNA complexation efficiencies were dependent on the 
DMAEMA percentage as well as on quaternization. More specifically, in the case of 
unquaternized PEG6000-based polymers, a 10-fold shift to higher mass ratios was observed 
between S1 (50% DMAEMA) and S3 (19% DMAEMA) (Figure 35 a vs. b). Likewise, while 
no major differences were observed between 91% and 66% DMAEMA in PEG2000-based 
polymers (T1 / T2), a > 100-fold shift to higher mass ratios was detected in T3 (26% 
DMAEMA) (Figure 35, c vs. d). Quaternized polymers showed generally higher 
complexation efficacies. This was especially true for the direct comparison of quaternized / 
unquaternized polymers with lower DMAEMA percentages, where 10 - 100-fold higher 
complexation efficacies were observed upon quanternation (Figure 35, b vs. e).  
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Figure 35: Complexation efficacies of selected copolymers S1 (a), S3 (b), T2 (c), T3 (d) and 
S7 (e) with DNA. Gel bands represent complexed and free DNA, respectively. 
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Beyond biological efficacies, the suitability of the polymers as gene delivery vectors is 
determined by their (absence of) toxicity. Therefore, we assessed the in vitro cytotoxicity of 
the polymers in cell viability assays (Figure 36). Dependent on the polymer, cytotoxicity was 
observed only at concentrations > 1 - 10 µg/ml, with T2 being the only exception. All 
quaternized polymers showed lower cytotoxicity than their unquanternized counterparts. Also, 
while no clear correlation was found between cytotoxicity and DMAEMA percentage, 
PEG6000-based polymers were less cytotoxic than polymers containing PEG2000. 
Particularly biocompatible were S5 and S6, but S1, T1 and T7, which showed best 
transfection efficacies (see below), displayed only low to moderate cytotoxicity as well.  
 
Figure 36: Dose-dependent cytotoxicity of the various copolymers. SKOV-3 ovarian 
carcinoma cells were incubated with the indicated polymer at various concentrations for 24 h, 
prior to the determination of cell viability. 
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Plasmid-DNA transfection efficacy . DNA transfection efficacies in the presence of serum 
were tested for the various polymers at different polymer/DNA ratios and with different 
complex amounts. Among the MDO ester group-containing  biodegradable polymers, highest 
luciferase expression was observed upon transfection with complexes based on copolymer T7 
(Figure 37). At the lowest mass ratio tested (mass ratio 5), luciferase activity was strongly 
dependent on the DNA amount transfected, with 3 µg DNA leading to the highest RLU values. 
However, profound luciferase expression was also observed at higher mass ratios, which also 
allowed to employ smaller DNA amounts (see e.g. Ratio 10, 0.25 µg DNA). Above mass ratio 
60 / 0.25 µg DNA, cell death was determined by microscopy, corresponding with the absence 
of luciferase activity, while at lower mass ratios no major impairment of cell viability was 
observed. Notably, quaternization markedly improved biological activity since the 
corresponding, unquaternized polymer T3 did not show appreciable transfection efficacy (data 
not shown). This is in contrast to previous results with other CKA (BMDO instead of MDO)-
based polymers, where higher activity was observed in the unquaternized polymer (early 
publication).64 It probably reflects the fact that the BMDO radical is less reactive, thus leading 
to a lower percentage of (hydrophobic) ester groups in these polymers which in turn translates 
into a higher rigidity and higher hydrophilicity with no beneficial effect of quaternization.  
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Figure 37: Transfection efficacies of complexes comprising the quaternized 57:43 
(MDO:DMAEMA) copolymer with plasmid-DNA and prepared at different polymer/DNA 
ratios, as determined by luciferase activities in SKOV-3 ovarian carcinoma cells. 
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 Conclusion 2.3.3
The aim of this study was to synthesize novel degradable, water soluble polymeric DNA 
transfection vectors with low toxicity.  Degradable and biocompatible poly(PEG-co-(MDO-
co-DMAEMA) were obtained via free radical polymerization using PEO macro-azo-initiator. 
The presence of MDO units onto the polymer backbone led to hydrolytic degradability. The 
water solubility is an essential prerequisite for their use as DNA delivery agents, and after 
quaternization, the solubility of the polymers as well as their complexation efficacies were 
greatly improved. Beyond favorable physicochemical data of the polymer/pDNA complexes 
with regard to hydrodynamic diameter and zeta potential, we demonstrate high 
biocompatibility and positive results in reporter gene transfection experiments in the presence 
of serum, and identify T7 as particularly efficient. Our poly(PEG-co-(MDO-co-DMAEMA) 
copolymers may thus represent promising vectors for in vivo applications with regard to the 
delivery of DNA or other therapeutic nucleic acids (Figure 38).  
 
Figure 38: Illustration of poly(PEG-co-(MDO-co-DMAEMA) forms polyplex with plasmid 
DNA and shows positive gene expression. 
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Chapter III: Degradable Polymers for Drug Delivery  
3.1 Biocompatible and Degradable Poly(2-Hydroxyethyl 
Methacrylate) based Polymers for Drug Delivery 
Applications 
Zhang, Yi; Chu, Dafeng; Zheng, Mengyao; Kissel, Thomas; Agarwal, Seema; Polymer 
Chemistry 2012, DOI:10.1039/c2py20403g 
  Introduction 3.1.1
Poly (2-hydroxyethyl methacrylate) (PHEMA) is a widely used and researched biocompatible 
polymer. Every repeat unit of PHEMA has one hydroxyl (-OH) group which makes the 
polymer highly hydrophilic and shows less or practically no tendency to adhere to proteins. It 
is an outstanding material for many different biomedical applications like scaffolds for tissue 
engineering, soft contact lenses, artificial skin and drug delivery systems for water soluble 
drugs etc..81–83 However, PHEMA has a C-C backbone and is therefore neither hydrolysable 
nor enzymatically degradable. For many biomedical applications degradability is important. 
There are some efforts in literature to provide degradability to PHEMA gels. This is done by 
primarily by using degradable cross-linkers. For example, the use of disulfide –S-S- cross-
linkage has been reported by Galaev et al.84 S-S- linkages are stable under oxidizing 
conditions, but can be broken down into thiol groups in a reductive environment. They used a 
water soluble disulfide cross-linker, N,N’-bis(methacryloyl)-L-cystine for cross-linking 
PHEMA chains and showed disintegration of the gel with a reducing agent like dithiothreitol. 
The use of hydrolytically and enzymatically degradable oligomeric polycaprolactone (PCL), 
as a cross-linker for PHEMA chains was also prepared.85 Peptide based cross-linkers have 
also been used to provide degradability to PHEMA gels. Enzymatically degradable hydrogels 
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based on HEMA and poly (ethylene oxide) PEO cross-linker having tripeptide like Gly-Gly-
Leu have been researched by Mésini et al.86 The cross-linked gels were degraded by the 
enzyme subtilisin in about 50 days.  
In all these representatively cited examples, the PHEMA chain remained as such after 
degradation. In the last few years, we have provided many new materials like degradable 
thermoplastic elastomers, ionomers, gene transfection systems etc. by introducing ester 
linkages onto the vinyl polymer C-C backbone.12,87–89 Radical-ring-opening copolymerization 
of cyclic ketene acetals like 2-methylene-1,3-dioxepane (MDO) and 5,6-benzo-2-methylene-
1,3-dioxepane (BMDO) with vinyl monomers has been a promising method for introducing 
degradable ester linkages into the C-C polymer backbones. Cyclic ketene acetals (CKA) are 
the isomers of the corresponding cyclic lactones and can undergo radical addition at the vinyl 
double bond with subsequent ring-opening leading to the formation of esterbonds in the 
polymer backbone. Utilising similar radical ring-opening polymerization chemistry of CKAs, 
biocompatible PHEMA could also be made degradable i.e. simply by copolymerization of 
HEMA and CKAs.  
The main question of this work is whether it is possible that ester linkages be randomly 
brought onto the PHEMA backbone and if so, how this can be done. If this can be 
successfully done, this would provide a new hydrophilic hydroxyl functionalised degradable 
polymer for biomedical applications. The initial efforts of copolymerizing HEMA with CKA 
like BMDO for introducing degradable ester linkages on its backbone were not successful. 
Detailed analysis has shown that the proton (from HEMA) addition to the double bond of 
BMDO was preferred in contrast to the expected ring-opening BMDO HEMA 
copolymerization. Therefore, protection-deprotection chemistry at hydroxyl (-OH) group of 
HEMA has been used for copolymerization with BMDO. The resulting PHEMA has ester 
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linkages randomly distributed on the backbone. The polymers were shown to be 
biocompatible and degradable. The exemplary use of resulting polymers for drug 
encapsulation has also been shown. 
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 Experimental Part 3.1.2
Instrumentation. One dimensional NMR 1H (300 MHz) and 13C (100 MHz) spectra were 
recorded on a Bruker DRX-300 spectrometer. Tetramethylsilane was used as internal standard. 
1H–13C correlation experiments were performed on a Bruker DRX-500 spectrometer, with a 
5 mm multinuclear gradient sample and using gs-HMQC (heteronuclear multiple quantum 
coherence) and gs-HMBC (heteronuclearmultiple bond coherence) pulse sequences. The 
HMQC experiment was optimized for C-H coupling of 140 Hz, with decoupling applied 
during acquisition, while the HMBC experiment was optimized for coupling of 8 Hz, with 
decoupling during acquisition.   
The molecular weight and the polydispersity of the synthesized polymers were measured with 
Gel Permeation Chromatography (GPC) using a Knauer system at 25 °C using DMF with 
LiBr as eluting solvent. Molecular weights were calculated using PMMA calibration; toluene 
was used as an internal standard. The GPC had a 50 × 8 mm2 precolumn and three linear 10 
m polyester columns (GRAM, PSS) 300 × 8 mm2. The injector volume was 50 L and the 
polymer concentration was 1 mg/mL. DMF with 5 g/L LiBr was used as eluent at a flow rate 
of 1 mL/min. The software PSS WinGPC Unity (Build 5403) from Polymer Standards 
Service GmbH was used for evaluation of the elugramms. 
Synthesis of Protected HEMA Monomer (HEMA-TMS). 40 mL HEMA (42.92 g, 0.33 mol) 
were placed in a 250 mL flask. The flask was cooled with an ice bath and Hydrochinon (100 
mg, 0.9 mg) were added. Then 34.4 mL of 1,1,1,3,3,3-hexamethyldisilazane (HMDS) (26.62 
g, 0.16 mol) were slowly added to the solution. After addition of HMDS, two drops of TMSCl 
were added as catalyst. The reaction mixture was stirred at room temperature (18 °C) for 24 h. 
The reaction was monitored with gas chromatography (GC). In the GC, only one peak could 
was observed after 24 h. The reaction mixture was dried with MgSO4 for 10 min. Then the 
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solution was filtered and distilled under high vacuum. The final product was received as a 
clear liquid.  
1H NMR,  (300 MHz, CDCl3, ppm): 6.10 (s, H2C=C, 1H), 5.54 (s, H2C=C, 1H), 4.20 (t, O-
CH2-CH2-OSi, 2H), 3.80 (t, O-CH2-CH2-OSi, 2H), 1.92 (s, CH3, 3H), 0.10 (s, Si-CH3, 9H) 
Copolymerization of HEMA / HEMA-TMS and BMDO. All the polymerization reactions 
were carried out under argon using AIBN (azobis isobutyronitrile) as initiator. In a typical 
polymerization reaction the monomer BMDO (0.99 g, 6.1 mmol) was dissolved in HEMA-
TMS (1.18g, 6.1mmol) in a predried Schlenk tube under argon atmosphere. The reaction 
mixture was degassed by three freeze-pump-thaw cycles. The AIBN (4.95 mg, 0.37 mmol) 
was added to the still frozen solution. The Schlenk tube was then sealed, evacuated and 
backfilled with argon (procedure was repeated three times) then immersed immediately in a 
preheated oil bath at 70 °C for 24 h. Afterwards the Schlenk tube was taken out of the oil bath 
and shock cooled in an ice bath. The reaction mixture was soluble in chloroform. It was then 
diluted with chloroform and precipitated in 200 mL pentane. The polymer was recovered by 
centrifugation, and dried at 40 °C for 48 h. Similar procedure was used for making 
copolymers with HEMA and HEMA-TMS of different copolymer compositions. For 
copolymers having more than 50% HEMA in the feed ratio, cold MeOH was used as 
precipitating agent.  
For deprotection of the TMS group, 1 g of the polymer obtained above was dissolved in 25 
mL THF, 0.65 g (10.8 mmol) of KF and 0.03 g (0.1 mmol) of Tetra-n-butylammonium 
fluoride (TBAF) was added. This mixture was stirred for 24 h. THF was partly evaporated 
and the mixture was then precipitated in n-pentane. The product was redissolved again in THF 
and the precipitated in 200 mL distilled water containing two drops of HCl. After filtration, 
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the white polymer was then dried under vacuum at 40 °C for 72 h. The structure of the 
polymer was then analyzed with 1H and 13C NMR. 
Cytotoxicity Studies. The cell cytotoxicity test (MTT (3 (4,5-dimethyl-thiazol-2-yl)-2,5-
diphenyl tetrazolium bromide) assay) was performed according to the method of Mosmann.67 
Polymer solutions were prepared in serum supplemented tissue culture medium (Dulbecco’s 
modified Eagle’s medium, supplemented with 10% serum, without antibiotic) containing 
2×10-3 M glutamine and sterile filtered (0.2 µm, Schleicher & Schüll, Dassel, Germany). 
24 h before the MTT assay, L929 cells (8000 cells/well) were seeded into 96-well plates 
(Nunc, Wiesbaden, Germany). On the day of the MTT assay, the culture medium was 
replaced by 200 L serial diluted polymer medium solution with different concentration. 
After a further 24 h incubation at 37 °C, the cell culture medium were replaced with 200 L 
medium containing 20 L sterile filtered MTT (Sigma, Deisenhofen, Germany) stock solution 
in phosphate buffered saline (PBS) (5 mg/mL) in each well. The final concentration of MTT 
in each well was 0.5 mg/mL. After 4 h incubating at 37 °C in the dark, the medium was 
removed and 200 µL DMSO were added in each well to dissolve the purple formazane 
product. The measurement was performed spectrophotometrically with an ELISA reader 
(Titertek Plus MD 212, ICN, Eschwege, Germany) at wavelengths of 570 nm and 690 nm. 
Culture medium without cells was used as reference to set zero point for calibration of the 
spectrometer. The relative viability (%) related to control wells containing cell culture 
medium without polymer was calculated by the following equation: 
(A 570) test (A 690) testRelative cell growth (A 570) control (A 690) control
−
=
−
     (4)   
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Random poly(D,L-lactide-co-glycolide) (PLGA) (PLGA 21 kDa, Boehringer Ingelheim, 
Germany) was used as a positive control. The IC50 value was calculated using the Boltzman 
sigmoidal function from Microcal Origin1 v 7.0 (OriginLab, Northampton, USA). It shows 
the polymer concentration, which inhibits growth of half of the cells relative to non-treated 
control cells. 
Hydrolytic Degradation. The hydrolysability of the polymers was tested under basic 
conditions using 5 wt.% KOH water solution. The degradability was followed using mass loss 
(by gravimetry) and molecular weight determination by GPC. The polymer films were made 
using a laboratory press (Polystat 200 T, Schwabenthan, Berlin, Germany). The polymers 
were compressed at 20 bar and 140 °C in 1 mm thick stainless steel molds for 10 min. This 
system cooled down to room temperature using cold water. The film thickness was 1.02 ± 
0.05 mm. It was cut into small pieces with a weight around 300±10 mg/piece. The films were 
placed separately in a 5 wt.% KOH water solution at 37 °C in a vibrator for different time 
intervals. After a certain time the film was taken out of the solution and washed with water. 
Then the film was dried in a freeze dryer for 48 h and the weight lost was determined. For 
each degradation study three films were used and the average of the weight was then 
calculated. The molecular weight of the remaining undegraded films was determined with 
GPC. 
Macrophages-mediated Degradation. J774A macrophages were maintained in DMEM 
containing 4.5 g/L of  D-glucose, sodium pyruvate, L-glutamine, 10% of fetal bovine serum, 
1%  of Antibiotic-Antimycotic Solution (v/v) (PAA, Germany). Cells were passaged every 3-
4 days by scraping. The seeding density was approximately 3.6 and 7.2×104 cells/cm2. The 
volume of the used medium used was 1 mL for each well. The study was divided into three 
groups for two cell concentration and one control medium (n=3). In group one the 
 Chapter III: Degradable Polymers for Drug Delivery 
 
 
82 
 
3.6×104 cell/cm2 concentration was used. In group two 7.2×104 cells/cm2 concentrations was 
used. Polymer films were first sterilized with isopropanol and then placed in the well plates 
(1 film/well). Macrophages were directly cultured on the surface of the film. For the control 
group films were not cultured with cells. After 10 days of culturing, the polymer film was first 
observed via microscopy. Afterwards the polymer film was washed with water. After drying 
the weights of the residual films were determined. 
Nanoparticle Formation. Coumarin-6 loaded nanoparticles (NPs) were prepared by solvent 
displacement technique. 10 mg of polymer and 10 g of coumarin-6 were dissolved together 
in 1 mL acetonitrile or acetone. The resulting polymer solution was injected into a 
magnetically stirred (600 rpm) aqueous solution of 5 g water (filtered and double distilled) 
through an injection needle (0.6８  40 mm) at a constant flow rate (6.0 mL/min). After 
injection of the organic phase, the resulting suspensions were stirred for 4 h in a fume hood to 
remove the residual acetone.  
Determination of Encapsulation Efficiency. The encapsulation efficiency was calculated by 
determining the concentration of coumarin-6 in the NPs after centrifugation and freeze drying. 
Samples of 150 L were subjected to ultracentrifugation (Airfuge, Beckman Coulter, Krefeld, 
Germany) for 60 min with a 8000 rpm at room temperature. After centrifugation the 
supernatant was carefully removed. The NPs were rinsed with 100 L of distilled water and 
centrifuged twice. The remaining NPs were freeze-dried (Beta II, Christ, Osterode, Germany). 
The NPs containing the encapsulated coumarin-6 were dissolved in acetonitrile and the 
concentration was determined by fluorescence spectroscopy (BMG Labtech, Offenburg, 
Germany) with excitation wavelength at 457 nm and emission wavelength at 500 nm. The 
calibration curve was established in the range of 10-50 ng/g (R2 > 0.99). Encapsulation 
 Chapter III: Degradable Polymers for Drug Delivery 
 
 
83 
 
efficiency (EE) was calculated by comparing the actual and theoretical loading of coumarin-6. 
Experiments were conducted in triplicates. 
Measurement of Particle Size and -potential. The average particle size and size 
distribution were determined by dynamic light scattering using a Zetasizer NanoZS/ZEN3600 
(Malvern Instruments, Herrenberg, Germany). -potential was measured by laser Doppler 
anemometry using the same device. The analysis was performed at 25 °C. The Dispersion 
Technology Software V. 6.01 was used to calculate particle mean diameter, the width of the 
fitted Gaussian distribution, which is displayed as the polydispersity index (PDI) as well as 
the average -potential values. Measurement of 10 runs each was performed in triplicate after 
the NPs preparation. 
In Vitro Coumarin-6 Release Studies. The release of coumarin-6 from NPs was investigated 
using a dialysis method (MWCO 100 kDa) at 37 °C under 50 rpm with 0.5 g of coumarin-6 
loaded NPs solution against 25 g of 0.01 M phosphate buffer, 140 mM NaCl, pH 7.4 / ethanol 
(70 : 30, w/w) to create sink condition for poorly water soluble coumarin-6. At certain time 
points, 1 mL of the release medium was drawn and replaced with fresh medium. The amount 
of coumarin-6 released in each time interval was determined by fluorescence spectroscopy 
with excitation wavelength at 472 nm and emission wavelength at 506 nm. The calibration 
curve was established in the range of 2-100 ng/g (R2 > 0.99). Experiments were conducted in 
triplicates. 
 
 
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 Results and Discussion 3.1.3
Synthesis and Structural Characterization.  
 
Scheme 3: Different probable polymer structures possible on copolymerization of HEMA and 
BMDO. 
Free-radical copolymerization of HEMA and BMDO was carried out in an effort to make 
hydroxyl functionalized polymers with hydrolysable ester linkages in the backbone. The 
initial efforts of copolymerizing HEMA with BMDO by radical polymerization were not 
successful. Detailed NMR analysis showed the presence of many different moieties of 
polymer structures as compared to the expected copolymerization (Scheme 3). In general, the 
copolymerization of BMDO with vinyl monomers provides either the ring-opening reaction 
with the formation of ester linkages onto the polymer backbone and or copolymerization with 
ring-retained BMDO structure (polyacetal formation) (Scheme 3, structures A and B). In the 
present work, in addition to it, we also observed the proton (from HEMA) addition at double 
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bond of BMDO leading to two new structures with ring-retained and ring-opened BMDO in 
the polymer side chain (structures C and D; Scheme 3). 
2D NMR like HMQC and HMBC were used to analyse the complex polymer structure. 13C 
NMR of the reaction product showed two strong peaks at 116.0 ppm and 116.3 ppm. These 
two peaks showed no correlation in 2D HMQC spectrum and therefore proved them to be 
quaternary carbons (Q-Cs). One of the reasons for the origin of Q-Cs could be acetal structure 
formation by ring-retaining vinyl polymerization of BMDO at its double bond (structure B, 
Scheme 3). This is a very common reaction that can occur during copolymerization of CKAs 
with vinyl monomers depending upon the comonomer, initiator, temperature etc. and is 
known in the literature.87 One of these Q-Cs peak at 116.0 ppm showed three strong cross-
signals (A, B, C) in 2D HMBC NMR spectrum (Figure 39A) with –OCH2 peaks at 5.1 ppm 
and 4.7 ppm attached to aromatic ring of BMDO (the correlation of these peaks with aromatic 
carbonyl was observed in HMBC but not shown here) and the backbone –CH2 at 1.6 ppm. 
This confirmed the ring-retained structure of BMDO (B, Scheme 3). In addition the other Q-C 
peak at 116.3 ppm showed a strong correlation with peaks at lower 3.4 ppm (D) and 1.7 ppm 
(E). The peak at 3.4 ppm derives from –OCH2 group of HEMA type repeat unit (the 
corresponding peak at 51.5 ppm in 13C NMR as determined by 2D HMQC NMR – not shown 
here) as there was no correlation with aromatic and carbonyl peaks in 13C NMR. The peak at 
3.4 ppm was from –OCH2 proton marked 1 in structure C of HEMA derivative (Scheme 3). 
This gave the hint about structure C (Scheme 3) formed by proton addition at the double bond 
of BMDO and further polymerization. This structure was confirmed by observing correlation 
of the peak at 1.7 ppm (E) (–CH3 group showed a correlation in HMQC with peak at 
19.8 ppm) with Q-C peak at 116.3 ppm. The complexity of the reaction product was further 
seen while analysing carbonyl carbon region in 13C NMR. Two groups of carbonyl signals 
 Chapter III: Degradable Polymers for Drug Delivery 
 
 
86 
 
were seen that is one group of multi signals between 176.0-178.5 ppm and the second 
between 169.0-172.0 ppm (Figure 39B). The group of multi signals in the range from 176.0-
178.5 ppm were from HEMA carbonyl units as they showed many correlations with -OCH2, 
backbone –CH2 and –CH3 protons in 2D HMBC NMR spectrum. The other signals between 
169.0-172.0 ppm could be from the ring opening of BMDO and were proved by careful 
analysis of 2D HMBC NMR spectrum. The carbonyl signal at 172.3 ppm correlated with –
OCH2, -CH2-C(O) and –CH2-Ar (marked 2, 3 and 4 in Scheme 3 structure A protons of 
BMDO units after ring-opening and showed respective correlations as H, I and J in Figure 39. 
The main proof for structure D in Scheme 3 was the correlation of carbonyl peak at 170.8 
ppm with –CH3 group (2.1 ppm) (K in Figure 39) observed in 2D HMBC NMR. The peak 
from the methyl group peak at 2.1 ppm did not show any other correlation. The proton 
addition at the double bond of BMDO was also observed previously for the reaction with 
acrylic acid.87 It was not possible to determine quantitatively the amount of each species in 
the polymer because of overlapping peaks in 1H NMR spectrum. The other most common 
problem during radical homo- and co-polymerization of HEMA like cross-linking due to 
transesterfication or transfer reactions to polymer and/or monomer was not seen in the present 
system as the polymers were soluble in common organic solvents.90,91 
 Chapter III: Degradable Polymers for Drug Delivery 
 
 
87 
 
 
Figure 39: 2D HMBC correlation spectra A) 13C region is from 115.0-118.0 ppm B) 13C 
region is from 170.0 – 175.0 ppm. 
Therefore, in order to achieve the targeted ester containing PHEMA, protection-deprotection 
chemistry at hydroxyl group of HEMA was employed. A three step reaction was performed as 
shown in Scheme 4. 
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Scheme 4: The synthetic route to the functional degradable polymer: poly(HEMA-co-ester). 
In the first step, the OH group of HEMA monomer was protected using TMS as a protective 
group. The protection reaction was followed by gas chromatography (GC) and the protected 
HEMA (HEMA-TMS) was characterized with 1H NMR and found to be quantitative with 
more than 99% protection. The copolymerization reaction of BMDO with HEMA-TMS was 
then performed at 70 °C for 24 h using different feed ratios of the two comonomers (Table 5). 
The obtained polymers were structurally characterized by NMR. 13C NMR in Figure 40 
shows a comparison of the polymers obtained after reaction of BMDO with protected HEMA 
(HEMA-TMS) to the reaction product with unprotected HEMA (described above). No peak 
was observed around 116 ppm in all the copolymers using protected HEMA (HEMA-TMS) 
showing quantitative ring-opening and no ring-retained structures from BMDO (therefore 
structures B and C of Scheme 3 were ruled out). A representative 1H NMR of one of the 
copolymers is shown in Figure 41. All characteristic peaks of ring-opened BMDO and HEMA 
TMS were observed. The signal from methyl group at around 2.0 ppm showing only 
correlation with carbonyl carbon in HMBC as seen and explained above for polymer product 
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with unprotected HEMA (HMBC not shown here). This ruled out the presence of the structure 
D of Scheme 3 also and showed formation of copolymers with ester linkages from ring-
opening reaction of BMDO in the back bone, which means successful formation of 
poly(BMDO-co-HEMA-TMS) (Structure A Scheme 3). 
 
Figure 40: A comparison of 13C NMR spectra of reaction product of BMDO with A) protected 
HEMA (HEMA-TMS) and B) unprotected HEMA. Ring-retained structures are visible in 
spectrum B. 
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Figure 41: 1H NMR spectra A) of poly(BMDO-co-HEMA-TMS) (sample R2 Table 1) and B) 
same polymer after deprotection. 
Moderate molecular weight copolymers with unimodal GPC curves could be made depending 
on the copolymer composition (Table 5). The molecular weights were determined using 
DMF-LiBr as eluent relative to PMMA standard using UV detector. Although they do not 
represent true molecular weights but were appropriate in giving rough approximation of the 
chain lengths. The real molecular weight is approximately half of the value determined by 
GPC in DMF-LiBr eluent (PMMA as calibration standard) as shown by Matyjaszewski et al. 
for PHEMA and MMA-HEMA block copolymer.90,92 The copolymer composition was 
determined by taking the ratio of peak areas under the peak at 5.0 ppm (characteristic of 
BMDO units) and 3.6 ppm (characteristic of HEMA units). Different copolymers with varied 
amounts of ester units could be made by changing the feed ratio (Table 5).  
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Table 5: Reaction conditions and copolymer characterization: free radical copolymerization 
was carried out using AIBN (0.25 mol-%) as initiator and different molar ratios of HEMA-
TMS and BMDO at 70 °C for 24 h. 
Sample 
name 
Feed 
composition 
HEMA-
TMS:BMDO 
Copolymer 
compositiona 
HEMA-
TMS:BMDO 
Mn 
Poly(BMDO-
co-HEMA-
TMS) 
PDI 
Mw/Mn 
Mn 
Poly 
(BMDO-
co-
HEMA) 
PDI 
Mw/Mn 
Yield 
% 
R1 25:75 57:43 26000 1.9 20000 1.8 39 
R2 50:50 67:33 42000 1.8 30000 1.7 55 
R3 70:30 82:18 86000 2.0 63000 1.9 62 
R4 90:10 93:7 340000 3.3 220000 2.5 79 
a as determined from 1H NMR 
To get an insight into the copolymerization behavior, for one specific initial feed (HEMA-
TMS:BMDO = 1:1) polymerization reactions at five different intervals of time were 
investigated (Table 6). Both HEMA and BMDO content continuously increased with 
increasing reaction time. The yield and the copolymer composition remained constant after 
about 18 h of reaction time. The incorporation of HEMA-TMS was much faster in the 
copolymers than BMDO (Table 6; Figure 42).  
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Figure 42: Caption Comparison of monomer (HEMA-TMS and BMDO) reactivity during free 
radical polymerization at 70 °C; (HEMA-TMS:BMDO 1: 1 molar ratio in feed, AIBN = 
0.25 mol %) 
 
The change of the copolymer composition over time showed the formation of random 
copolymers with long sequences of HEMA-TMS at the beginning followed by more 
randomization at the end of the polymerization. This was also supported by determination of 
reactivity ratios. Five copolymerizations with different monomer feed ratios were carried out 
at 70 °C till low conversions to determine the reactivity ratios (Table 7). All the conversions 
were between 8 and 12%. The reactivity ratios were calculated using Kelen-Tüdos method 
applicable for higher conversions (Figure 43) and showed r HEMA-TMS = 7.6±1.6 and r 
BMDO = 1.2±0.4.93 The error of the reactivity ratio was calculated with 95% joint-confidence 
interval.94 
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Figure 43: Kelen-Tüdos plot for poly (BMDO-co-HEMA-TMS) (values based on Table 3). 
Table 6: Free radical bulk copolymerization of HEMA-TMS and BMDO (1:1 molar ratio) 
using AIBN as initiator for different time intervals temperature of polymerization = 70 °C, 
AIBN = 0.25 mol %). 
Sample 
Name 
Reaction 
Time 
Copolymer 
Composition 
Conversion Fraction of 
Monomer Reacteda) 
Mn 
KDa 
PDI 
 min HEMA-
TMS 
BMDO % HEMA-
TMS 
BMDO   
  mol% mol%  wt.% wt.%   
T1 30 84.8  15.3 9   17 1 68 1.4 
T2 180 80.6 19.4 16   28 4 45 1.5 
T3 420 74.1 25.9 39   61 19 41 1.8 
T4 1080 66.5 33.5 56   77 35 35 2.1 
T5 1440 66.7 33.3 55   76 34 32 2.1 
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Table 7: Free radical bulk copolymerization of HEMA-TMS and BMDO using AIBN as 
initiator with different feed compositions. Reactions were stopped at low conversions for 
reactivity ratio calculations by Kelen-Tüdos method (temperature of polymerization = 70 °C, 
AIBN = 0.25 mol %). 
 
TMS-deprotection of the polymers was done using KF and Tetra-n-butylammonium fluoride 
(TBAF) as described in the experimental section. Quantitative deprotection of the hydroxyl 
groups (as seen by 1:1 peak ratio of –OCH2 protons of HEMA at 4.1 ppm and 3.8 ppm in 1H-
NMR) was possible without cleaving backbone ester linkages (Figure 41B). The molecular 
weights after deprotection for all the samples are tabulated in the Table 5. Figure 44 shows the 
comparison of GPC chromatograms before and after deprotection for one of the representative 
sample (R2). There was a decrease in molecular weight due to TMS removal but 
polydispersity remained almost same before and after deprotection. Also, no tailing was seen 
in GPC chromatograms and therefore also ruled out degradation of polymer backbone during 
deprotection of TMS.  
Sample Name Feed Ratio Yield Copolymer Composition 
 
HEMA-
TMS 
BMDO % HEMA-
TMS 
BMDO 
 mol% mol%  mol% mol% 
K1 75 25 9 94 6 
K2 50 50 12 85 15 
K3 40 60 10 80 20 
K4 30 70 11 74 26 
K5 20 80 8 67 33 
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Figure 44: Comparison of GPC chromatograms of Sample R2 before and after deprotection of 
TMS group. 
 
The hydrolytic degradation behavior of poly(BMDO-co-HEMA) was studied under basic 
(5 wt.% KOH) conditions and proved the random distribution of ester linkages onto the 
polymer backbone. The polymer was compressed at 20 bar and 140 °C using a 1 mm thick 
stainless steel mold for 10 min to a 1 mm thick film. This film was treated with 5 wt.% KOH 
for 48 h. The mass loss and the molecular weight of the polymer film were determined 
(Figure 45). After 17 h the film lost more than 50% mass, after 48 h only 20% polymer film 
remained (Figure 45A). The remaining films were completely soluble in chloroform and 
showed a reduced molecular weight (Mn = 2 kDa), which indicated the degradation of the 
polymer due to randomly distributed ester linkages (Figure 45B). The deprotected polymers 
were used further for cytotoxicity, degradation and drug release studies. 
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Figure 45: A) Mass loss profile of the poly (HEMA-co-BMDO) film (deprotected T3) after 
incubation with 5 wt.% KOH at 37 °C for different time intervals; B) GPC elugramms of 1) 
poly (HEMA-co-BMDO) film (deprotected T3, before degradation) and 2 after degradation in 
5 wt.% KOH).  
 
Cytotoxicity Test with MTT Assay. To evaluate the cytotoxicity of the synthesized 
copolymers, MTT assay was performed with L929 cells. The cell viability of the synthesized 
copolymers was compared with the well-known biocompatible polymer PLGA, which is 
usually used for drug delivery applications. The polymer concentrations between 0.01 mg/mL 
and 100 mg/mL were tested. The cell viability diagrams are shown in Figure 46. The 
polymers made in this work showed very high cell viabilities, even at high concentrations 
(100 mg/mL), the poly(BMDO-co-HEMA) had cell viability higher than 90%.  
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Figure 46: Cytotoxicity of polymer (deprotected R2) in comparison to well-known 
biocompatible PLGA studied by MTT assay. L929 cells were incubated with polymer of 
different concentrations for 24 h 
 
Degradation Test with J774A Macrophages Cells. The macrophages mediated degradation 
of poly(BMDO-co-HEMA) was also tested and analyzed with Microscope. J774A 
macrophages cells were used and cultured on the polymer film for 14 days with two different 
concentrations 3.6 ×104 cells/cm2 and 7.2 ×104 cell/cm2. After treating the polymer film with 
cell medium for 2 weeks, holes were visible indicating degradation (Figure 47A). The black 
color in the microscopic pictures was the polymer film. The mass loss of the polymer film is 
shown in Figure 47B and increased with the cell concentration. With 3.6×104 cell/cm2 the 
polymer film lost around 35% mass. The polymer film lost 54% mass with 7.2×104 cell/cm2. 
The remaining film with low cell concentration was not soluble in chloroform. The DMF 
GPC showed almost no change in the molecular weight which indicated the surface erosion of 
the films. In contrast, when the polymer film is incubated with high cell concentration, the 
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remains of the polymer film were soluble in chloroform and showed drastic change in the 
molecular weight (Figure 47C). A multimodal distribution showing dispersity in molecular 
weight after degradation could be observed. The signal at elution volume of 11 mL had a 
molecular weight of 6 kDa and the other signal at 9 mL volume had a molecular weight of 
17 kDa. This indicates that the degradability of the copolymers depends on the cell 
concentration. 
 
 
Figure 47: J774A macrophages mediated degradation data for poly(BMDO-co-HEMA) film 
(deprotected T3) after 10 days of culturing A) Microscope pictures; a) original film b) 
cultured with 3.6×104 cell/cm2 cells, c) 7.2×104 cell/cm2; B) relative mass after 10 days of 
cell culturing with low cell concentration  of cells (3.6×104 cell/cm2) and high concentration 
of cells (7.2×104 cell/cm2); C) GPC profiles showing degradability; 1) original sample 2) after 
10 days of cell culturing with 7.2×104 cell/cm2. 
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Preparation and characterization of Nanoparticles (NPs) and in vitro drug delivery.  
Nanoparticle preparation loaded with coumarin-6 was performed by solvent displacement 
method without any additional surfactant (Figure 48A).68,95 The properties of coumarin-6 
loaded NP are summarized in Table 8. The polymer formed NPs with narrow PDI in the 
desired size range below 200 nm and negatively charged surface. Almost all the coumarin-6 
was entrapped in the NPs which can be explained by extreme hydrophobicity of coumarin-6 
and also the good NP forming nature of the polymer. Release profile was determined using 
membrane dialysis which is a valuable system for drug release studies from nanocarriers.96 
The nanocarriers can be easily separated from the release buffer, without any shear forces 
affecting the particle integrity. To achieve sink condition for the poorly water-soluble 
compound, 30 vol% ethanol was added as a co-solvent. A retarded drug release was observed 
and about 36%, 60% and 83% of the drug were released, after 1 h, 3 h, 8 h, 16 h and 24 h, 
respectively. The release was completed (>90%) after 24 h (Figure 48B), which will be 
sufficient for drug delivery and targeting to specific regions. Comparable experiments were 
carried out using only coumarin-6. A burst release was observed and more than 80% was 
released in 2 h. 
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Figure 48: A) Procedure of making coumarin-6 encapsulated NPs by solvent displacement 
method from deprotected T3 sample and in vitro release studies  B) release profile in 
PBS/ethanol (70/30, w/w), pH 7.4 at 37 °C. 
Table 8: Physicochemical characterization of coumarin-6 loaded NPs. Values were presented 
as the mean±standard deviation (n=3). 
Size (nm) PDI -potential (mV) Encapsulation efficiency (%) 
81.9 ± 4.7 0.091 ± 0.021 -30.2 ± 1.8 98.2 ± 0.7 
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 Conclusion 3.1.4
Biocompatible and degradable functional polymers based on HEMA could be synthesized 
successfully by radical polymerization. The structure of the resulting polymers was 
unambiguously proved by 2D NMR techniques. The cell viabilities were over 80% even for 
very high polymer concentrations (100 mg/ml). The hydroxyl functionalized polymers 
synthesized in this work were hydrolytically degradable under basic conditions and also 
showed surface erosion and bulk degradation using macrophages. Degradation using 
macrophages was concentration dependent. We have also demonstrated promising positive 
results for the use of such polymers for drug encapsulation. Although further modification of 
this system to tune the sustained delivery rate is under progress in our laboratory, we have 
already provide a new, well characterized biocompatible and degradable hydroxyl 
functionalized polymer suitable for many different biomedical applications. 
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Chapter IV: Antibacterial Application 
4.1 Design and Synthesis of Antibacterial Hydrogel 
 Introduction 4.1.1
Hydrogels like crosslinked poly(2-hydroxyethyl methacrylate) (PHEMA) are widely used for 
biomedical applications.97 Therefore, microbial contamination is a major concern in fields 
such as medical treatment, because bacterial contamination leads to severe infections and 
serious threats to human health. Another drawback of this kind of superabsorber is the non-
degradability of the polymer backbone. 
The aim of this study was to synthesize and characterize a degradable hydrogel with 
antibacterial properties (Figure 49). 
 
Figure 49: Illustration of a poly(BMDO-co-HEMA-graft-DMAEMA) film for water 
absorption and antibacterial (both Bacillus Subtilis and E. coli) applications. 
For the design of an antibacterial polymer the differences of the bacterial cell membranes and 
walls have to be considered. While Gram-positive bacteria possess a cell wall composed of a 
single phospholipid bilayer covered by a up to 80 nm thick layer of murein, Gram-negative 
bacteria exhibit two phospholipid bilayers in their cell membrane with a 3 nm thin layer of 
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murein in between.98 Antibacterial polycations targeting the cell membrane are therefore often 
more active against Gram-positive bacteria, although the polymer needs to penetrate the thick 
murein layer (Figure 50). 
 
Figure 50: Illustration of the differences of the grambacterial cell membranes and walls.98 
Poly(2-dimethylaminoethyl methacrylate) (PDMAEMA) is well known as antimicrobial 
material, which inhibits growth of both Gram-positive and Gram-negative bacteria.99 
PDMAEMA is able to diffuse through the thick layer of murein to reach the cell membrane. 
Due to its polycationic character it can adsorb onto the negatively charged cell membrane. 
The hydrophobic part of PDMAEMA can then enter the cell membrane and bind membrane 
lipids to itself, which are then extracted from the membrane leaving a hole, which ultimately 
kills the bacterium.  
For optimal antibacterial activity, the molecular weight and the amphiphilic balance are very 
important structural factors. To achieve a tunable polymer chain length and macromolecular 
architecture, controlled polymerization methods like Atom Transfer Radical Polymerization 
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(ATRP) and Reversible Addition Fragmentation Chain Transfer (RAFT) were intensively 
investigated for the polymerization of PDMAEMA.100,101 Recent studies used different 
lengths of the alkyl chain of alkyloxylethylammoniun ionenes to optimize the hydrophilic and 
hydrophobic balance.102  
The strategy of this work is based on a combination of an antibacterial polymer and a 
hydrogel moiety synthesized via ATRP. A degradable polymer poly(HEMA-co-BMDO), 
which contains hydroxyl groups in the side chain, was used as polymer backbone. The 
hydroxyl groups subsequently can be partially functionalized as ATRP initiator moieties, 
which enables grafting of antibacterial PDMAEMA side chains with different chain lengths. 
The remaining hydroxyl groups which were not converted into ATRP initiator functionalities 
can be further on used as crosslinking sites for the transesterfication reaction between 
poly(HEMA-co-BMDO) side chains.103 This eventually resulted in an antibacterial hydrogel. 
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 Experimental Part 4.1.2
Material. DMAEMA (Acros, 99%) was passed through a basic alumina column to remove 
the inhibitor. PMDETA and anisole were dried using molecular sieves overnight (4 Å) and 
distilled before use. All other solvents were purified by destillation. Compost was received 
from Marburger Entsorgungs-GmbH (Marburg, Germany). All other chemicals were obtained 
from Sigma-Aldrich (Steinheim, Germany) and used as received. 
Instrument. 1H-NMR (300 MHz) and 13C-NMR (100 MHz) spectra were recorded on a 
Bruker DRX-400 spectrometer. Tetramethylsilane was used as internal standard.  
Elemental Analysis. Elemental analysis was carried out at the central analytic service of 
chemistry department at Philipps Universität Marburg. It was performed by combustion 
analysis, where a sample was burned in an excess of oxygen and the combustion products 
nitroxide (NO), carbondioxide (CO2) and water (H2O) were collected in various traps. The 
weights of these combustion products were determined and used to calculate the composition 
of the samples. Br analysis was accomplished by Schoeniger oxidation of the sample, 
followed by titration with AgNO3. The weights of the precipitates (AgBr) were used to 
calculate the composition of the analyzed sample. The weight fraction (w/w) of carbon (C), 
hydrogen (H), nitrogen (N) and bromine (Br) was given as result. 
Synthesis of the PDMAEMA Grafted Polymer via ATRP Method. 
Synthesis of ATRP Macroinitiator. A random copolymer poly(BMDO-co-HEMA) with 
33 mol% of BMDO, 67 mol % of HEMA and a molar weight of 34 kDa was synthesized as 
described previously.104 0.8 g of poly(BMDO-co-HEMA) was mixed with 0.5 mL Et3N 
(3.3 mmol) and a catalytic amount of DMAP in 20 mL absolute THF at 0 °C. 0.5 mL of 2-
bromo-2-methylpropiomyl bromide (3.3 mmol) was added slowly to the reaction mixture. 
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This reaction mixture was stirred overnight at rt. After centrifugation at rt for 30 min at 10000 
rpm, the liquid phase was then precipitated in n-pentane. Purification of the precipitated 
polymer was performed by dissolving the crude product in CHCl3 and reprecipitating in n-
pentane. The polymer was lyophilized for 2 days at the freeze dryer. The yield was 71%. 1H-
NMR (300 MHz, CDCl3), δppm: 7.0-7.5 (Ar, m, 4H), 5.0 (CH2-Ar, m, 2H), 3.8-4.2 
(COOCH2CH2, m, 4H from HEMA), 2 ((CH3)2CBr, s, 6H), 1- 3 (m, other methyl and 
methylene). Elemental analysis (wt.%) C : H : Br = 50.2 : 5.6 : 21.6. That means 95 mol% of 
OH groups from HEMA were converted into ATRP initiator. 
Polymerisation of DMAEMA. A typical polymerization reaction is described for sample 2: 
33.7 mg of macroinitiator (0.1 mmol, 0.06 mmol of bromine active initiator part) and 2 mL of 
DMAEMA (12 mmol) monomer were dissolved in 2 mL absolute anisole in a Schlenk 
tube.105 12 µL of PMDETA (0.06 mmol) was added to the reaction solution, which was 
degassed three times by freeze-pump-thaw cycles. 8.5 mg of copper(I)-bromide (0.06 mmol) 
were added to the frozen mixture. The reaction flask was quickly evacuated and purged with 
argon three times. The reaction was then carried out for 2 h in an oil bath at 90 °C.106 
Afterwards, the reaction was stopped by shock cooling with liquid nitrogen. The reaction 
vessel was opened and excess water was added. The final product was then purified by 
dialysis (MWCO 20 kDa) against deionized water. (Yield: 78%, 43 wt.% PDMAEMA in 
graft polymer, Elemental analysis (wt.%) C : H : N = 62.7 : 8.4 : 3.8). 
For sample 1, 1 mL of DMAEMA (6 mmol) monomer was dissolved in 1 mL absolute anisole. 
(Yield: 75%, 32 wt.% of PDMAEMA in graft polymer, Elemental analysis (wt.%) C : H : N = 
63.0 : 8.1 : 2.9). 
For sample 3, 3 mL of DMAEMA (18 mmol) monomer were dissolved in 3 mL absolute 
anisole. (Yield: 70%, 58 wt.% of PDMAEMA in graft polymer, Elemental analysis (wt.%) C : 
H : N = 62.2 : 8.7 : 5.2). 
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Swelling Measurements. 50 mg of the polymer was added to 50 mL of different water 
solutions. The weight of the polymer was determined before and after different times. 
For the pH dependent test, pH 5, pH 7 and pH 9 buffers were used. For the temperature 
influence test, distilled water at temperatures of 4 °C, rt and 50 °C was tested. For the 
repetitive water uptake, 50 mg polymer was treated with 50 mL of pH 7 buffer solution for 
24 h. Then, the polymer weight was determined and dried afterwards.  
Each analysis was performed in the same manner three times. Results were visualized 
including the calculated errors using Microcal Origin1 v 7.0 (OriginLab, Northampton, 
U.S.A.). 
Compostability Test. The polymer film (0.5 mm × 0.5 mm) was placed in compost in a 
plastic container (500 mL size) at 45 °C for several days. This compost was ventilated each 
day for 5 min. 2 mL water was added to the container each two days. After 30, 60 and 90 days 
the film was recovered, washed with distilled water and then dried using a freeze dryer for 
three days. The weight loss of the film was determined gravimetrically. This procedure was 
carried out with three polymer films.  
Preparation of Bacteria Suspension. For the Gram-negative antibacterial test, a single 
colony of Escherichia coli (E. coli) (DSM No. 1077, K12 strain 343/113), was transferred 
from the stem nutrient agar plate to liquid nutrient (tryptic soy broth, Sigma Aldrich, aqueous 
solution c = 30 g/L) using an inoculation loop. The suspension was incubated at 37 °C with 
shaking until the optical density at 578 nm indicated that a concentration of 108 cfu/mL E. coli 
was obtained OD578 = 0.125. The suspension was diluted to an approximate concentration of 
106 cfu/mL for further tests; the exact amount of bacteria was determined by spreading serial 
tenfold dilution on nutrient tryptic soy agar plates followed by colony counting after 
incubation for 24 h at 37 °C.107 
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For the Gram-positive strain, Bacillus Subtilis (DSM No. 1088), peptone meat extract medium 
was used as nutrient (Sigmal-Aldrich, aqueous solution meat extract c = 5 g/L, peptone from 
soybean meal, enzymatic digest. C = 3g/L). Bacillus Subtilis inocula were prepared 
analogously to the procedure described for E. coli. 
Minimum Inhibitory Concentration (MIC)/ Minimum Bactericidal Concentration 
(MBC). To determine the MIC (as described in DIN 58940-6), a suspension of the biocide in 
liquid nutrient was prepared with different concentrations. In a microcentrifuge tube, each 
500 µL solution as well as a blank control were inoculated with 500 µL E. coli or Bacillus 
Subtilis inoculum. After incubation for 24 h at 37 °C, bacteria growth was monitored visual 
evaluation of the test solutions for turbidity. The lowerst polymerconcentration, which 
inhibited bacteria growth, i.e. remained clear was taken as MIC.107  
The solutions which showed no bacteria growth were spread on nutrient agar plates and 
incubated for 24 h at 37 °C. The lowest polymer concentration which did not lead to colony 
formation was taken as MBC.  
Time Dependent Antibacterial Activity. To determine the time dependence of the 
antibacterial activity, 2 mL inoculum was incubated at rt with different amounts of 
poly(BMDO-co-HEMA-graft-DMAEMA) in microcentrifuge tubes. Serial tenfold dilutions 
of 100 µL aliquots in sterile phosphate buffer, drawn after different contact times, were spread 
on nutrient agar plates and incubated for 24 h at 37 °C. The number of viable cells after each 
immersion period was determined by colony counting.102  
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 Results and Discussion 4.1.3
Synthesis of the PDMAEMA Grafted Polymer via ATRP Method. 
 
Scheme 5: Synthetic route to PDMAEMA grafted copolymer poly(BMDO-co-HEMA-graft-
DMAEMA).  
The synthetic route is based on the degradable linear polymer poly(BMDO-co-HEMA) with a 
molecular weight of 33 kDa, 67 mol% HEMA and 33 mol% BMDO content. The synthesis 
method of poly(HEMA-co-BMDO) was described in an earlier publication.104 In the first step, 
the macro ATRP initiator poly(BMDO-co-HEMA-Br) was synthesized. A bromine content of 
21.6 wt.% was determined via elemental analysis. 21.6 wt.% of Br were detected by elemental 
analysis. Conclusively, 95 mol% of hydroxyl groups from HEMA were converted into ATRP 
initiator. In the next step, DMAEMA was grafted onto the side chain of the ATRP macro 
initiator using copper(I) bromide as catalyst and PMDETA as ligand (Scheme 5).  
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By controlling the amount of the monomer DMAEMA, the amount of PDMAEMA in the 
final product poly(BMDO-co-HEMA-graft-DMAEMA) was adjusted. Since the polymer is 
not soluble in any solvent, the PDMAEMA content in the product was determined by 
elemental analysis. PDMAEMA was grafted with 32 wt.%, 43 wt.% and 58 wt.% on the side 
chain. 
Swelling Studies 
Reduction of Hydrogen Bond Formation. The synthesized polymer poly(BMDO-co-
HEMA-graft-DMAEMA) (43 wt.% PDMAEMA) shows high water uptake efficiency. It can 
absorb about 2600 wt.% of water. Within 25 min, the polymer could reach around 84% of the 
maximum water uptake efficiency (Figure 51).  
The water uptake efficiency was reduced to about 40% in the present of potassium 
thiocyanate, a hydrogen bond breaker. 
 
Figure 51: Water uptake efficiency of poly(BMDO-co-HEMA-graft-DMAEMA) (43 wt.% 
PDMAEMA) with  and without potassium thiocyanate influence. 
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Effect of Amount of PDMAEMA on Swelling Properties. Different amounts of 
PDMAEMA grafted on the poly(HEMA-co-BMDO) also influence the water uptake 
efficiency (Figure 52). It is known that water absorption is highly influenced by the 
crosslinking grade. The polymer with 43 wt.% of PDMAEMA on the side chain has shown 
the highest water uptake result. The polymer with the highest PDMAEMA content (58 wt.%) 
showed the lowest water uptake efficiency. However, it could still absorb more the 1600 wt.% 
of water.  
 
Figure 52: Water uptake efficiency of p(BMDO-co-HEMA-graft-DMAEMA) (32 wt.%, 43 
wt.% and 58 wt.% PDMAEMA) with  different PDMAEMA length.  
Temperature Effect on Water Uptake Efficiency. Temperature can influence the water 
uptake efficiency as well. Experiments were carried out with sample 2 (43 wt.% PDMAEMA 
in graft polymer) at 4 °C, 25 °C and 50 °C (Figure 53). At 4 °C, poly(BMDO-co-HEMA-
graft-DMAEMA) showed about 5% reduction in the maximum water uptake efficiency. The 
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water uptake speed is much faster at 25 °C and 50 °C than at 4 °C. At rt and 50 °C the 
polymer sample showed similar water uptake results, however water uptake was fastest at 
50 °C. After only 2 min the water uptake was at 1630 wt.%. After 4 min it showed 2060 wt.% 
of water uptake. 
 
Figure 53: Water uptake efficiency of poly(BMDO-co-HEMA-graft-DMAEMA) (43 wt.% 
PDMAEMA) at  different temperatures. 
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PH Depending Water Uptake. The pH dependent water uptake efficiency was tested using 
buffer solutions with different pH values (Figure 54). The test results showed that the water 
uptake efficiency can be controlled by different pH values. The water uptake increased with 
decreasing pH (Figure 55). At pH 5 the polymer could reach a maximum water uptake of 
4430 wt.%. Within 2 min it could reach a water uptake of 2190 wt.% at pH 5. At pH 9 it was 
only 430 wt.% of water uptake after 2 min. The lower pH provides a high water uptake at a 
high speed. Figure 55 shows the same amount of poly(BMDO-co-HEMA-graft-DMAEMA) 
in buffer solutions with different pH values after 2 min. It is clearly visible, that the polymer 
at lower pH has the largest volume. 
 
Figure 54: Water uptake efficiency of p(BMDO-co-HEMA-graft-DMAEMA) (43 wt.% 
PDMAEMA) in buffer solution with different pH values. 
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Figure 55: The morphology of poly(BMDO-co-HEMA-graft-DMAEMA) (43 wt.% 
PDMAEMA) in buffer solutions with different pH values after 2 min (pH value from left to 
right: 9, 7, 5). 
The higher water absorption ability at lower pH is explained in Figure 56. At lower pH more 
of the amine groups on the polymer side chain are protonated than at higher pH. More 
hydrogen bonds can be formed between water and protonated amine groups. Because of this, 
water can be absorbed in the gaps between the side chains of the polymer. At lower pH the 
polymer chains are more stretched due to the water between the side chains and show a bigger 
volume than at higher pH. 
 
Figure 56: Illustration of water uptake efficiency at different pH values. 
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Repetitive Water Uptake. To further test the water uptake efficiency, experiment was 
performed using the same sample for 5 cycles. The sample was dried after treatment with 
buffer solution and treated again with the buffer solution (Figure 57). It showed a minimal 
reduction of water uptake efficiency after the first cycle. Then it reached a stable plateau. This 
shows, that the material can be reused as a water absorber. 
 
Figure 57: Water uptake efficiency repetition of poly(BMDO-co-HEMA-graft-DMAEMA) 
(43 wt.% PDMAEMA) in pH 7 buffer solution at rt for 5 cycles. 
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Compostability Test. The degradation of the graft polymer film was tested using the compost 
method. The weight loss was determined after 30, 90 and 120 days. The polymer film lost 3% 
weight after 30 days, after 90 days about 7%, after 120 days 9%. The images of the polymer 
film (43 wt.% PDMAEMA) before and after 120 days degradation (after drying) are shown in 
Figure 58. Conclusively, the polymer can be slowly degraded in compost. 
 
Figure 58: Illustration of the polymer film (43 wt.% PDMAEMA) before and after 120 days 
(after drying) in compost at 45 °C.  
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Antibacterial Test. All of the grafted polymers poly(HEMA-co-BMDO-graft-DMAEMA)  
were tested for their antibacterial activity against representative Gram-negative E. coli 
bacteria and Gram-positive Bacillus Subtilis. The MIC and MBC values are shown in 
Figure 59.  
 
 
Figure 59: MIC and MBC values of poly(BMDO-co-HEMA-graft-DMAEMA) (32 wt.%, 
43 wt.% and 58 wt.% PDMAEMA (samples 1, 2 and 3)) against E. coli and Bacillus Subtilis. 
 
The sample 3 with 58 wt.% of DMAEMA showed the best antibacterial activity. It was 
antibacterial with a MBC against E. coli of smaller than 31.25 mg/mL, with a MBC against 
Bacillus Subtilis of also smaller than 31.25 mg/mL. It showed the optimal hydrophilic and 
hydrophobic balance for killing bacteria. All the polymers are antibacterial against both gram 
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negative and Gram-positive bacterial strains. The antibacterial activity against Bacillus 
Subtilis was better than against E. coli because of the additional membrane that has to be 
penetrated in Gram-negative bacteria.  
The time dependent antibacterial test was performed with a polymer concentration of 
2 mg/mL. All the synthesized polymers can kill more than 99.9% against E. coli within 1 min. 
Figure 60  shows that after contact for 1 min with 43 wt.% PDMAEMA grafted polymer, 
99.91% of the bacteria were killed, after 30 min 99.99% of the bacteria were killed. Graft 
polymer with the highest amount of PDMAEMA on the side chain (58 wt.%) has the highest 
antibacterial effect. After 1 min contact with sample 3 more than 99.99% bacteria were killed. 
 
Figure 60: Time dependent antibacterial test against E. coli ) (32 wt.%, 43 wt.% and 58 wt.% 
PDMAEMA (samples 1, 2 and 3)). 
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 Conclusion 4.1.4
The aim of this study was to synthesize degradable polymers with high water absorption 
ability and antibacterial effect. Poly(BMDO-co-HEMA-graft-DMAEMA) was synthesized 
using a new macro ATRP initiator and shows up to 4430 wt.% of water uptake. The water 
uptake efficiency of the copolymers with different side chain PDMAEMA length was tested 
at different pH and temperature values. At higher temperature and at lower pH the polymer 
with 43 wt.% of DMAEMA on the side chain shows the highest water uptake efficiency. 
Poly(BMDO-co-HEMA-graft-DMAEMA) demonstrated high antibacterial activity against 
both E. coli and Bacililus Subtilis up to 31.25 µg/mL. The time dependent antibacterial test 
showed a 99.9% antibacterial activity within 1 min. Besides the high water absorption ability 
and high antibacterial activity, the polymers could also be slowly degraded under compost 
condition.  
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Chapter V: Summary 
5.1 Summary 
In this thesis degradable polymers for three different purposes, DNA transfection, drug 
delivery and antibacterial properties were designed, synthesized and characterized.  
In the first part of the DNA transfection application the novel degradable and biocompatible 
poly(PEG-co-(BMDO-co-DMAEMA)) and its quaternized derivative poly(PEG-co-(BMDO-
co-DMAEMA·EtBr)) were successfully synthesized and characterized. This copolymer shows 
a significant solubility improvement by introducing hydrophilic PEG blocks into the polymer 
backbone. The successful incorporation of ester linkages into the copolymer backbone led to a 
fast degradation of the copolymer under enzymatic and buffer conditions. All the synthesized 
copolymers show a low cytotoxicity. The unquaternized copolymers result in higher cell 
viability than the quaternized copolymers as well as positive results in p-DNA transfection. 
In the second part of the DNA transfection application degradable and biocompatible 
poly(PEG-co-(MDO-co-DMAEMA)) and the quaternized derivative poly(PEG-co-(MDO-co-
DMAEMA·EtBr)) were obtained also via free radical polymerization using PEG 
macro-azo-initiator. The presence of the PEG unit in the polymer backbone led to great 
improvement of the polymer solubility. The more reactive MDO leads to a higher ester 
content in the copolymer than with BMDO as monomer. After quaternization of poly(PEG-
co-(MDO-co-DMAEMA), the solubility of the polymers as well as their complexation 
efficiencies were greatly improved. This highly biocompatible polymer shows a positive 
result in the gene transfection experiments in the presence of serum. 
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For the drug delivery application, a biocompatible and degradable functional polymer which 
is based on HEMA could be successfully synthesized by radical polymerization. The structure 
of the resulting polymers and the reaction kinetics was studied in this work. The cell 
viabilities were over 80 % even for very high polymer concentrations (100 mg/ml). The 
hydroxyl functionalized polymers are hydrolytically degradable under basic conditions and 
also show surface erosion and bulk degradation upon treatment with macrophages. A 
promising positive result is demonstrated for the use of such polymers for drug encapsulation. 
This new, well characterized biocompatible and degradable hydroxyl functionalized polymer 
could be suitable for many different biomedical applications. 
For the antibacterial application, poly(BMDO-co-HEMA-graft-DMAEMA) with different 
DMAEMA side chain lengths was synthesized using a new macro ATRP initiator. A high 
water absorption ability of these copolymers can be observed. At higher temperature and 
lower pH the polymer with 43 wt.% of DMAEMA shows the highest water uptake efficiency. 
Poly(BMDO-co-HEMA-graft-DMAEMA) demonstrates great antibacterial activities against 
both E. coli and Bacillus Subtilis down to concentrations as low as 31.25 µg/mL. The time 
dependent antibacterial test shows that 99.9 % of the treated E. coli bacteria were killed 
within 1 minute. This polymer also presents slow degradation ability under compost condition.  
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5.2 Perspectives 
This thesis was done particularly in regard to methods of design, synthesis and 
characterization and new materials have been made. Basic work for future projects has been 
carried out. Therefore a variety of possible research directions for further work has been 
obtained. 
For the DNA transfection material project, the MDO and BMDO based polycationic gene 
vectors show positive results in DNA transfection experiments. An optimization of the 
different monomer ratios in the copolymer to enhance the transfection efficiency and to lower 
the cytotoxicity will be of great importance in the future. For further research, it is necessary 
to investigate DNA and RNA delivery into living cells.108 The synthesized polymer shows 
degradation ability under physiological condition. Moreover, it is interesting to determine the 
in vivo degradation in animals. 
For the drug delivery material project, the in vitro drug delivery efficiency was successfully 
performed using coumarin as model drug. Furthermore it will be very meaningful to 
investigate in vitro drug delivery tests with anticancer drugs like Paclitaxel. Afterwards it 
would be important to perform in vivo drug delivery tests for treatment of cancer. 
For the antibacterial material project, a polymer with excellent water uptake efficiency and 
high antibacterial activity against gram positive and gram negative bacteria was obtained. 
These properties can be of use for example for wound dressing as well as hygienic 
products.109 For these applications in vitro and in vivo test are necessary to determine the 
biodegradation products and to investigate whether it is non-antigenic. Other monomers can 
be incorporated in the polymer backbone to research their influence on the properties of the 
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crosslinked polymer, for example poly(N-acryloyl glycinamide) (NAGA)  to introduce UCST 
to have a smart, antibacterial super absorber.110  
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5.3 Zusammenfassung 
In dieser Arbeit wurden abbaubare Polymere für drei verschiedene Anwendungen designt, 
synthetisiert und charakterisiert: DNA-Transfektion, Wirkstofffreisetzungen und 
antibakterielle Materialien.  
Im ersten Teil der DNA-Transfektion wurden das neuartige abbaubare und biokompatible 
Poly(PEG-co-(BMDO-co-DMAEMA)) und das quaternisierte Poly(PEG-co-(BMDO-co-
DMAEMA·EtBr)) erfolgreich synthetisiert und charakterisiert. Durch die Einführung eines 
hydrophilen PEG-Blocks in das Polymerrückgrat konnte die Löslichkeit des Polymers in 
Wasser deutlich verbessert werden. Zusätzlich führte der erfolgreiche Einbau von 
Estergruppen in das Copolymerrückgrat zu einem schnellen Abbau des Copolymers unter 
enzymatischen und Pufferbedingungen. Alle synthetisierten Copolymere zeigten eine niedrige 
Zytotoxizität. Die quaternisierten Copolymere besaßen höhere IC50-Werte mit L929 Zellen als 
die unquaternisierten Copolymere und lieferten positive Ergebnisse bei Versuchen zu den p-
DNA-Transfektionen. 
Im zweiten Teil der DNA-Transfektionen wurde das abbaubare und biokompatible Poly(PEG-
co-(MDO-co-DMAEMA)) und das quaternisierte Polymer Poly(PEG-co-(MDO-co-
DMAEMA·EtBr)) mittels radikalischer Polymerisation unter Verwendung des PEG-Makro-
Azoinitiators synthetisiert. Die PEG-Einheit in der Polymerkette führte zu einer Verbesserung 
der Löslichkeit des Polymers. Die Verwendung des reaktiveren MDO an Stelle von BMDO 
als Monomer führte zu einem höheren Anteil an Esterbindungen im Copolymer. Nach der 
Quaternisierung von Poly(PEG-co-(MDO-co-DMAEMA)), zeigten die Polymere eine 
deutlich bessere Löslichkeit und Komplexierungseffizienz. Das biokompatible Polymer zeigte 
ein positives Ergebnis im Transfektionsexperiment in Gegenwart von Serum. 
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Für die Wirkstofffeisetzung wurde ein biokompatibles, funktionales und abbaubares Polymer, 
welches auf HEMA basiert Poly(BMDO-co-HEMA), erfolgreich durch radikalische 
Polymerisation synthetisiert. Die Struktur des resultierenden Polymers und die 
Reaktionskinetik wurden in dieser Arbeit untersucht. Die Überlebensrate der Zellen war höher 
als 80%, selbst bei sehr hohen Polymerkonzentrationen (100 mg/ml). Das hydroxyl-
funktionalisierte Polymer wurde hydrolytisch unter basischen Bedingungen abgebaut und 
zeigte Oberflächenerosion und Bulk-Abbau bei Verwendung von Makrophagen. Ein 
vielversprechendes positives Ergebnis wurde für die Verwendung solcher Polymere für 
Wirkstoffverkapselung festgestellt. Dieses neue, gut charakterisierte, biokompatible und 
abbaubare hydroxyl-funktionalisierte Polymer ist potenziell für viele verschiedene 
biomedizinische Anwendungen geeignet. 
Für die antibakterielle Anwendung wurde Poly(BMDO-co-HEMA-graft-DMAEMA) mit 
unterschiedlichen DMAEMA-Seitenkettenlängen unter Verwendung eines neuen Makro 
ATRP-Initiators synthetisiert. Eine hohe Wasseraufnahmefähigkeit dieses Copolymers konnte 
beobachtet werden. Bei höheren Temperaturen sowie einem niedrigeren pH-Wert zeigte das 
Polymers mit 43 wt.% DMAEMA an der Seitenkette die höchste Wasseraufnahmeeffizienz. 
Poly(BMDO-co-HEMA-graft-DMAEMA) zeigte eine hohe antibakterielle Aktivität gegen 
E. coli und Bacililus Subtilis bei Konzentrationen bis unter 31,25 µg/mL. Die zeitabhängigen 
antibakteriellen Tests ergaben eine antibakterielle Aktivität gegen E. coli von 99,9% innerhalb 
von 1 min. Dieses Polymer wies auch einen langsamen Abbau unter Kompostbedingungen 
auf. 
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 Appendices 7
7.1 Abbreviations 
AIBN azobisisobutyronitrile 
AMP adenosine monophosphate 
ATP adenosine triphosphate 
BMDO 5,6-benzo-2-methylene-1,3-dioxepane 
c concentration 
CAN acetonitrile 
CKA  cyclic ketene acetal 
CLSM confocal laser scanning microscopy 
DLS dynamic light scattering 
DMAEMA N, N-dimethylaminoethyl methacrylate 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DSC differential scanning calorimetry 
E. coli Escherichia coli 
GPC gel permeation chromatography 
HEMA (hydroxyethyl)methacrylate 
HEPES  2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid 
HMBC heteronuclear multiple bond coherence 
HMQC  heteronuclear multiple quantum coherence 
hy hyperbranched 
IC50 half-inhibitory concentration 
MBC minimum bactericidal concentration 
MDO 2-methylene-1,3-dioxepane 
MIC minimum inhibitory concentration 
min miunite 
Mn number-average molecular weight 
mol% molar percentage 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
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Mw weight-average molecular weight  
N/P ratio nitrogen to phosphate ratio 
NAGA poly(N-acryloyl glycinamide) 
NMR nuclear magnetic resonance 
NP nanoparticle 
PBS  phosphate buffered saline 
PCL polycaprolactone 
PDI polydispersity index 
p-DNA  plasmid DNA 
PEG  polyethylenglycol 
PEI  polyethylenimine 
pKa acidic association constant, -lg(Ka) 
PLGA poly(lactic-co-glycolic acid) 
r reactivity ratio 
RNA ribonucleic acid 
rpm revolutions per minute 
rt room temperature 
siRNA short interfering RNA 
SS disulfide 
Tg glass transition temperature 
TGA thermogravimetric analysis 
TMS trimethylsilyl 
UCST upper critical solution temperature 
wt.% weight percentage 
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